0920-0621 WISEWOMAN-MDE_Manual_23.1

[NCCDPHP] Well-Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) Reporting System

WISEWOMAN-MDE_Manual_23.1

WISEWOMAN Program Minimum Data Elements (MDE)

OMB: 0920-0612

Document [pdf]

Download: pdf | pdf

OMB Number:
Expiration Date:

0920-0612
03/31/2025

WISEWOMAN
Program
MDE Manual
Edition 23.1

Public reporting burden of this collection of information is estimated to average 25 hours per
program including the time for reviewing instructions, searching existing data sources, gathering,
and maintaining the data needed, and completing and reviewing the collection of information. An
agency may not conduct or sponsor, and a person is not required to respond to a collection of
information it displays a currently valid OMB control number. Send comments regarding this burden
estimate or any other aspect of this collection of information, including suggestions for reducing this
burden to CDC/ATSDR Reports, Clearance Officer, 1600 Clifton Road NE, MS D-74, Atlanta, GA
30333. Attn: PRA (0920-0612). Do not send the completed form to this address.

CONTENTS
1. INTRODUCTION................................................................................................................... 1
2. ADMINISTRATIVE MDE SPECIFICATIONS ......................................................................... 4
a. Summary of Administrative MDEs ................................................................................... 5
b. Administrative MDE Specifications ................................................................................... 6
Item 1a: StFIPS* ......................................................................................................... 6
Item 1b: HdANSI* ....................................................................................................... 7
Item 1c: EnrollSiteID* .................................................................................................. 8
Item 1d: ScreenSiteID*................................................................................................ 9
Item 2a: TimePer* ..................................................................................................... 10
Item 2b: NScreen* .................................................................................................... 11
Item 2c: Type* .......................................................................................................... 12
Item 2d: Navigation*.................................................................................................. 13
Item 3a: EncodeID* ................................................................................................... 14
3. DEMOGRAPHIC MDE SPECIFICATIONS .......................................................................... 15
a. Summary of Demographic MDEs................................................................................... 17
b. Demographic MDE Specifications .................................................................................. 18
Item 3b: ResANSI*.................................................................................................... 18
Item 3c: ZIP* ............................................................................................................. 19
Item 3d: MYB*........................................................................................................... 20
Item 3e: Latino*......................................................................................................... 21
Item 3f: Race1* ......................................................................................................... 22
Item 3g: Race2 ......................................................................................................... 23
Item 3h: Education .................................................................................................... 24
Item 3i: Language ..................................................................................................... 25
4. HEALTH HISTORY AND MEDICATION USE MDE SPECIFICATIONS .............................. 27
a. Summary of Health History and Medication Use MDEs.................................................. 28
b. Health History and Medication Use MDE Specifications ................................................. 29
Item 4a: SRC* ........................................................................................................... 29
Item 4b: SRHA* ........................................................................................................ 30
Item 5a: Meds* ......................................................................................................... 32
Item 5b: Aspirin* ....................................................................................................... 34
Item 5c: MedAdhere* ................................................................................................ 35
5. BEHAVIORAL MDE SPECIFICATIONS ............................................................................. 37
a. Summary of Behavioral MDEs ....................................................................................... 39
b. Behavioral MDE Specifications ...................................................................................... 40
Item 5d: Monitored .................................................................................................... 40
Item 6a: BPHome ..................................................................................................... 41
Item 6b: BPFreq........................................................................................................ 42
Item 6c: BPSend ....................................................................................................... 43
Item 7a: FruitVeg* ..................................................................................................... 44
Item 7b: Fish* ........................................................................................................... 45
Item 7c: Grains* ........................................................................................................ 46
Item 7d: Sugar*......................................................................................................... 47
Item 7e: SaltWatch* .................................................................................................. 48
Item 7f: AlcFreq ........................................................................................................ 49
Item 7g: AlcDay ........................................................................................................ 50
Item 8a: PA* ............................................................................................................. 51
WISEWOMAN MDE Manual
Edition 23.1

iii

Item 9a: Smoker* ...................................................................................................... 52
Item 10a: PHQ*......................................................................................................... 53
6. CLINICAL VALUE MDE SPECIFICATIONS ......................................................................... 54
a. Summary of Clinical Value MDEs .................................................................................. 55
b. Clinical Values MDE Specifications ................................................................................ 56
Item 11a: Height* ...................................................................................................... 56
Item 11b: Weight* ..................................................................................................... 57
Item 11c: Waist ......................................................................................................... 58
Item 12a: BPDate* .................................................................................................... 59
Item 12b: SBP* ......................................................................................................... 60
Item 12c: DBP* ......................................................................................................... 62
Item 13a: Fast* ......................................................................................................... 64
Item 14a: TotChol* .................................................................................................... 65
Item 14b: HDL* ......................................................................................................... 67
Item 14c: LDL* .......................................................................................................... 69
Item 14d: Trigly ......................................................................................................... 71
Item 15a: Glucose* ................................................................................................... 73
Item 15b: A1C* ......................................................................................................... 75
Item 16a: BPAlert...................................................................................................... 77
Item 16b: BPDiDate .................................................................................................. 78
7. RISK REDUCTION COUNSELING MDE SPECIFICATIONS .............................................. 79
a. Summary of Risk Reduction Counseling MDEs ............................................................. 80
b. Risk Reduction Counseling MDE Specifications............................................................. 81
Item 17a: RRCComplete*.......................................................................................... 81
8. HEALTHY BEHAVIOR SUPPORT SERVICES MDE SPECIFICATIONS ............................ 82
a. Summary of Healthy Behavior Support Services MDEs ................................................. 83
b. Healthy Behavior Support Services MDE Specifications ................................................ 84
Item 18a: RefDate* ................................................................................................... 84
Item 19a: LSPHCRec* .............................................................................................. 85
Item 19b: Intervention ............................................................................................... 86
Item 19c: LSPHCID .................................................................................................. 87
Item 20a: TobResDate .............................................................................................. 88
Item 20b: TobResType ............................................................................................. 89
9. SOCIAL DETERMININANTS OF HEALTH MDE SPECIFICATIONS .................................. 91
a. Summary of Social Determinants of Health MDEs ......................................................... 92
b. Social Determinant of Health MDE Specifications .......................................................... 93
Item 21a: CompUse* ................................................................................................ 93
Item 21b: IntAcc* ...................................................................................................... 94
Item 21c: FoodInsec ................................................................................................. 95
Item 21d: TranBarr.................................................................................................... 96
Item 21e: Childcare ................................................................................................... 97
Item 21f: ChildBarr .................................................................................................... 98
Item 21g: Housing..................................................................................................... 99
Item 21h: IntPartViol ............................................................................................... 100
Item 21i: MedAdher................................................................................................. 101
Item 22a: SocSerID* ............................................................................................... 102
Item 22b: SocSerDate* ........................................................................................... 103
Item 22c: SocSerUtil* .............................................................................................. 104
APPENDIX A: ASSESSMENT DEFINITIONS AND SUBMISSION GUIDANCE ......................... 1
WISEWOMAN MDE Manual
Edition 23.1

Assessment Definitions ......................................................................................................... 1
Data Conventions .................................................................................................................. 3
Submission Procedures......................................................................................................... 9
Data Confidentiality and Security ........................................................................................... 9
APPENDIX B: DATA QUALITY AND VALIDATION................................................................... 1
Validation of Data .................................................................................................................. 2
Data Validation Procedures and Forms ................................................................................. 3
Error Rate Calculation Method .............................................................................................. 4
Validation of Data Form ......................................................................................................... 5
Participant ID Change Form .................................................................................................. 6
Correction to Previous MDE File Form .................................................................................. 7
Supplemental Lifestyle Program and Health Coaching (LSP/HC) Session Spreadsheet ........ 8
APPENDIX C: DATA ANALYSIS AND USE............................................................................... 1
Data Use by CDC.................................................................................................................. 2
Potential Data Use by Funded Programs............................................................................... 2
APPENDIX D: TECHNICAL ASSISTANCE RESOURCE ........................................................... 1
Types of Technical Assistance Available ............................................................................... 2
Helpdesk for Individualized Technical Assistance Requests .................................................. 3
APPENDIX E: NUTRITIONAL PROMPTS .................................................................................. 1

WISEWOMAN MDE Manual
Edition 23.1

1. INTRODUCTION
This WISEWOMAN MDE Manual was written to provide guidance on the collection and
submission of minimum data elements (MDEs) for the Well-Integrated Screening and
Evaluation for Women Across the Nation (WISEWOMAN) Program of the Centers for
Disease Control and Prevention (CDC). The Program currently funds recipients of the
cooperative agreement across the United States to improve cardiovascular health among
low-income, underinsured, and uninsured participants 35 to 64 years of age. Funded
recipients are required to collect and report MDEs as part of standardized data reporting for
the WISEWOMAN Program.1 MDEs are used by CDC and its recipients to describe, monitor,
and assess progress and performance.
The MDEs in this manual (Edition 23.1) received final approval in August 2023 from the
Federal Office of Management and Budget. This manual pertains to the WISEWOMAN
cooperative agreement. Data for the 71 MDEs are separated into eight categories:
Administrative, Demographic, Health History and Medication Use, Behavioral, Clinical
Values, Risk Reduction Counseling, Healthy Behavior Support Services, and Social
Determinants of Health.
The MDE manual includes information about technical specifications for the MDE variables
included in each of the categories, guidance for their submission, and conventions for
processing the data. Specifications for each MDE include variable name, definition, format,
source of data, denominator population, acceptable values, description, and use for data
analysis. Please note that the format provided is relevant for data submitted by
recipients for a six-month reporting period. Variables are reported for each participant.
These values for each participant establish a record for their assessment visit. The manual is
organized as follows:
•

Administrative MDE Specifications. This category includes nine MDE variables. It
includes data about the recipient program, including its geography, provider sites,
aggregate assessments, and unique IDs of participants to track their health over time.

•

Demographic MDE Specifications. This category includes eight MDE variables. It
includes data about participant’s county of residence, their month and year of birth,
their race and ethnicity, educational attainment, and spoken language.

•

Health History and Medication Use MDE Specifications. This category includes five
MDE variables. It includes data about participant’s medical history, their medication
use, and medication adherence.

•

Behavioral MDE Specifications. This category includes 14 MDE variables. It
includes data about participant’s health behaviors, such as self-measurement of blood
pressure, nutrition, physical activity, smoking status, alcohol consumption, and mental
well-being.

1 Throughout this document, capital “Program” refers to the CDC WISEWOMAN Program, and lower-case “program” refers
to the CDC-funded state/tribal recipients.

WISEWOMAN MDE Manual
Edition 23.1

•

Clinical Values MDE Specifications. This category includes 15 MDE variables. It
includes data about participant’s clinical assessment values as it relates to
cardiovascular disease risk factors.

•

Risk Reduction Counseling MDE Specifications. This category contains one
required MDE variable. It includes data about the risk reduction counseling received by
participants from a provider discussing their cardiovascular disease risk.

•

Healthy Behavior Support Services MDE Specifications. This category contains
seven required MDE variables. It includes data about the evidence-informed Lifestyle
Program/Health Coaching sessions available and received by participants as well as
referrals to community-based tobacco cessation resources.

•

Social Determinants of Health MDE Specifications. This category contains 12 MDE
variables. It includes data about evidence-based social determinants of health
variables, including information about internet and computer access, transportation,
housing, food insecurity, childcare, intimate partner violence, medication adherence,
and referral/attendance to social services.

•

Appendix A—MDE Assessment Definitions and Submission Guidance. Data are
required to be submitted semiannually, on June 1 and December 1 or the Monday
following if the 1st falls on a weekend. This appendix details assessment visit
definitions and submission guidance.

•

Appendix B—Data Quality and Validation. To promote high-quality, consistent data
across recipients, several tools are provided for use by recipients prior to MDE
submission and by CDC after submission. This appendix describes the various
validation procedures that recipients can use prior to submission and that CDC uses to
assess data quality. In addition, the method used to calculate the error rate is provided
for MDE submission files.

•

Appendix C—Data Analysis and Use. MDEs have several analytic purposes for
CDC and recipients, including (1) promoting public health practice through continuous
program improvement (2) measuring and improving program performance, (3)
assessing program health outcomes through evaluation, and (4) calculating
Atherosclerotic Cardiovascular disease Risk (ASCVD). This appendix describes the
summary report format, and the content produced and provided to recipients after
each submission. It also discusses use of the data by CDC as well as potential ways in
which recipients can utilize the data.

•

Appendix D—Technical Assistance Resources. Several technical assistance
resources are available to support recipients’ MDE data collection and reporting. This
appendix describes the various types of technical assistance resources that recipients
can access, including one-on-one technical assistance, group trainings, documents,
and tools available on the WISEWOMAN website. It describes the process for
requesting individual technical assistance and the response process for CDC and the
data contractor.

•

Appendix E –Nutritional prompts. This appendix includes a supplemental handout
with examples for MDE items sourced from American Heart Association’s Life’s
Simple 7.

WISEWOMAN MDE Manual
Edition 23.1

This manual is a living document that will be updated as needed. When changes are made to
it, CDC will notify recipients that the updated manual is available on the WISEWOMAN Data
Management System website [https://wwwn.cdc.gov/wisewoman].

WISEWOMAN MDE Manual
Edition 23.1

2. ADMINISTRATIVE MDE SPECIFICATIONS
This section provides recipients with the information necessary to support collection and
reporting of administrative MDEs, which must be done according to the specifications
provided in this section of the manual.
These variables provide key contextual information about the structure and operations of
recipient programs and are essential to the services provided through the program. For each
participant record, programs provide Federal Information Processing Standards/American
National Standards Institute (FIPS/ANSI) codes to perform geospatial analyses for public
health purposes. In addition, for the six-month submission period recipients must report for
each participant the enrollment site, assessment site, the type of assessment received, and
unique participant ID. Missing or invalid values for these variables will be considered errors.
This section begins with a summary of the nine required MDEs (Subsection a) and then
provides the technical specifications for each MDE (Subsection b).

WISEWOMAN MDE Manual
Edition 23.1

a. Summary of Administrative MDEs
Item
Number

Variable Name

Beginning
Position

Variable Label

Type

StFIPS

State/Tribal FIPS code

Character

HdANSI

ANSI Geographic code (provider)

Character

EnrollSiteID

Enrollment site ID

Character

ScreenSiteID

Screening (Assessment) site ID

Numeric

TimePer

Time period of Screening (Assessment)

Numeric

NScreen

Number of Screenings (Assessments) received
by the participant

Numeric

Type

Type of Screening (Assessment) visit

Numeric

Navigation

Were the navigation services paid for by
NBCCEDP funds, WISEWOMAN funds, Indian
Health Services/ Tribal funds, or other funds?

Numeric

EncodeID

Unique participant ID number

Character

WISEWOMAN MDE Manual
Edition 23.1

b. Administrative MDE Specifications
Item 1a: StFIPS*

State/Tribal FIPS Code
This variable indicates the FIPS or tribal program code for the state, tribal organizations, or
territory where the administration of the program is located.

FORMAT

Type:

Character

Other Format:

N/A

Item Length:

Justification:

Left

Field Length:

Beginning Position:

Leading Zeros:

Yes

Valid Range:

Static Field:

Yes

See values; cannot be
blank

SOURCE

National FIPS Code List

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessments.

VALUES AND
DESCRIPTION

National FIPS Code

ANALYSIS AND USE

To calculate the number of individuals assessed by each recipient
To assess the reach of the WISEWOMAN Program nationally and within a particular state, tribal
organization, or territory

Two-digit (character) value representing the identification of the
awardee that is providing services to the participant.

OTHER
INFORMATION

The state FIPS codes are the Federal Information Processing Standards codes developed by the
National Institute of Standards and Technology. The tribal program codes are codes assigned by
CDC to be used by tribal programs in lieu of FIPS.
Programs should always record the FIPS code for the state, tribal organizations, or territory
where their program is located. This may differ from the FIPS code for the participant’s state,
tribal organization, or territory of residence if the participant resides in a state, tribal organization,
or territory different from where the program is located. Any FIPS code that is not the same as
where the program is located will be flagged as an error.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 1b: HdANSI*

ANSI Geographic Code (Provider)
This indicates the ANSI geographic code of the provider that conducts the WISEWOMAN
assessment office visit.

FORMAT

Type:

Character

Other Format:

N/A

Item Length:

Justification:

Left

Field Length:

Beginning Position:

Leading Zeros:

Yes

Valid Range:

Valid ANSI code

Static Field:

SOURCE

National ANSI Code List, Census Bureau

DENOMINATOR
POPULATION

The denominator includes all assessment visits.

VALUES AND
DESCRIPTION

ANSI Geographic Code

ANALYSIS AND USE

To evaluate whether programs and specific providers are meeting assessment visit goals in
targeted geographic areas
To identify geographic areas where eligible individuals have access to the WISEWOMAN
Program
To provide information for geospatial analysis
To assist in identifying areas where there may be potential transportation barriers to accessing
WISEWOMAN services

OTHER
INFORMATION

Five-digit (character) value representing the geographic area of the
provider that conducts the assessment office visit.

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 1c: EnrollSiteID*

Enrollment Site ID
This variable indicates the site of a participant’s enrollment into the WISEWOMAN Program.

FORMAT

Type:

Character

Other Format:

N/A

Item Length:

Justification:

Left

Field Length:

Beginning Position:

Leading Zeros:

N/A

Valid Range:

Static Field:

Yes

Valid ZIP code; cannot be
blank

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessments.

VALUES AND
DESCRIPTION

Enrollment Site ID

ANALYSIS AND USE

To identify sites where outreach and enrollment are occurring
To identify sites where the Program is being administered and participants are tracked
To track the number of WISEWOMAN participants enrolled at each WISEWOMAN enrollment
site

Valid five-digit ZIP code for the location where the participant is
enrolled.

OTHER
INFORMATION

The enrollment site ID should be the ZIP code of the location where the participant is enrolled.
This may be the ZIP code for a provider site location if a provider conducts enrollment, or the
ZIP code of the recipient location if the recipient conducts enrollment of the participant.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 1d:
ScreenSiteID*

Screening (Assessment) Site ID
This variable indicates the site where a participant received their WISEWOMAN assessment.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:
Leading Zeros:

10
N/A

Beginning Position:
Valid Range:

Static Field:

13
Valid code for assessment
site; cannot be blank

SOURCE

National Provider Identifier

DENOMINATOR
POPULATION

The denominator includes all assessments.

VALUES AND
DESCRIPTION

Screening (Assessment)
Site ID

ANALYSIS AND USE

Value representing a National Provider Identifier for the provider
who conducts the assessment office visit.

To identify the geographic locations of sites providing assessments to participants
To track the number of WISEWOMAN participants screened at each WISEWOMAN
assessment site
To describe differences in participant demographics or other characteristics by assessment site
To provide information for geospatial analysis
To identify the number of assessments provided in each geographic area
To identify provider pool for assessment of health systems and providers that use clinical
systems of care successful in blood pressure control
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 2a: TimePer*

Time Period of Screening (Assessment)
This variable indicates the 6-month time period of the assessment visit for the participant.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Valid Range:

See values; cannot be blank

Static Field:

Yes

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all Complete/BP+ baseline assessments.

VALUES AND
DESCRIPTION

1 6-month period 1

Assessment took place between 09/30/23 and 03/31/24.

2 6-month period 2

Assessment took place between 04/01/24 and 09/29/24.

3 6-month period 1

Assessment took place between 09/30/24 and 03/31/25.

4 6-month period 2

Assessment took place between 04/01/25 and 09/29/25.

5 6-month period 1

Assessment took place between 09/30/25 and 03/31/26.

6 6-month period 2

Assessment took place between 04/01/26 and 09/29/26.

7 6-month period 1

Assessment took place between 09/30/26 and 03/31/27.

8 6-month period 2

Assessment took place between 04/01/27 and 09/29/27.

9 6-month period 1

Assessment took place between 09/30/27 and 03/31/28.

0 6-month period 2

Assessment took place between 04/01/28 and 09/29/28.

ANALYSIS AND USE

To track the number of assessments for each participant

OTHER
INFORMATION

Time period of assessment should be provided for each participant assessment.

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 2b: NScreen*

Number of Screenings (Assessments) Received by the Participant
This variable indicates the total number of assessments that the participant has received since
the beginning of the cooperative agreement.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Valid Range:

Cannot be blank

Static Field:

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Number of Visits

ANALYSIS AND USE

To track the number of assessments/ follow-up assessments/re-assessments

OTHER
INFORMATION

This field should include the number of assessments that the participant has received since the
beginning of the cooperative agreement.

Value representing the number of assessments that the participant
has received since the beginning of this cooperative agreement
(includes current assessment)
Any values outside 1 to 8 will be flagged for a quality check.

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 2c: Type*

Type of Screening (Assessment) Visit
This variable indicates whether the record represents a baseline assessment visit, a
reassessment visit, or a post-Lifestyle Program (LSP)/Health Coaching (HC) follow-up
assessment.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Valid Range:

See values; cannot be blank

Static Field:

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all assessments.

VALUES AND
DESCRIPTION

1 Baseline Assessment

Record represents a baseline assessment visit.

2 Reassessment

Record represents a reassessment visit.

3 Follow-up assessment (inperson)

Record represents an in-person follow-up assessment visit.

4 Follow-up assessment (athome)

Record represents an at-home follow-up assessment visit.

9 No answer recorded

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND USE

To assess the number of unique participants served by the WISEWOMAN Program
To track participants assessment values over time
To link baseline assessments with reassessments
To assess participant progress after completion of an LSP/HC

OTHER
INFORMATION

Baseline assessments, reassessments, and follow-up assessments will be classified as
complete, blood pressure plus (BP+), or incomplete based on the definitions in Appendix A.
Reassessments occur between 11 and 18 months following the previous assessment/reassessment.
Follow-up assessments occur between 3 and no later than 11 months after the previous
baseline assessment/ re-assessment and within 4 to 6 weeks after LSP/HC completion.

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 2d: Navigation*

FORMAT

Were the navigation services paid for by NBCCEDP funds, WISEWOMAN funds, Indian
Health Services/ Tribal funds, or other funds?
This variable indicates the funding source for navigation services for participants who receive
healthy behavior support services, but whose cardiovascular assessments are not funded by
WISEWOMAN.
Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be
blank

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all assessments.

VALUES AND
DESCRIPTION

NBCCEDP funds

Funding source for navigation services was paid by NBCCEDP
funds.

WISEWOMAN funds

Funding source for navigation services was paid by
WISEWOMAN funds.

Indian Health
Service/Tribal funds

Funding source for navigation services was paid by Indian Health
Services/ Tribal funds.

Other funds

Funding source for navigation services was paid by other funds.

Not Applicable

Not applicable

ANALYSIS AND USE

To track funding sources for navigation services for participants who receive healthy behavior
support services through the federally-funded WISEWOMAN program

OTHER
INFORMATION

WISEWOMAN participants who receive healthy behavior support services, such as health
coaching or lifestyle programs, but whose cardiovascular assessments are reimbursed through
an alternative payment source other than WISEWOMAN are considered navigated.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 3a: EncodeID*

Unique Participant ID Number
This variable indicates a participant’s unique identification number.

FORMAT

Type:

Character

Other Format:

N/A

Item Length:

Justification:

Left

Field Length:

Beginning Position:

Leading Zeros:

N/A

Valid Range:

Cannot be blank

Static Field:

Yes

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Unique Participant ID
Number

ANALYSIS AND USE

To assess the number of unique participants served by the WISEWOMAN Program
To track participants over time
To link baseline assessments with re-assessments
To link assessments with risk reduction counseling, lifestyle programs, health coaching, and
community-based resource referrals

OTHER
INFORMATION

A participant’s unique ID should not change over time. If it does change, the program should
provide the data contractor and Project Officer with a list of IDs that have changed at the time of
data submission and upload a crosswalk of the previous participant unique IDs to the new
participant unique IDs (see Appendix B).

Value representing the unique identifier for a participant

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

3. DEMOGRAPHIC MDE SPECIFICATIONS
This section provides recipients with the information necessary to support collection and
reporting of demographic MDEs, which must be done according to the specifications provided
in this section of the manual.
Demographic data elements characterize the participants served by our program and help
ensure the program activities are conducted through a health equity lens. Data elements in
this section include information about a participant’s county of residence, their month and
year of birth, their race and ethnicity, educational attainment, and spoken language.
For a record to be counted as a Complete or BP+ assessment, it must have valid values for
required MDEs. Definitions of complete and BP+ assessments are provided in
Appendix A.
This section begins with a summary of the eight MDEs (Subsection a) and provides the
technical specifications for each MDE (Subsection b).

WISEWOMAN MDE Manual
Edition 23.1

Blank Page

This Page Has Been Left Blank Intentionally

WISEWOMAN MDE Manual
Edition 23.1

a. Summary of Demographic MDEs
Item
Number
3b

Variable
Name

Beginning
Position

Variable Label

Type

ResANSI

ANSI geographic code of residence

Character

ZIP

ZIP code of residence

Character

MYB

Month and year of birth

Numeric

Latino

Hispanic or Latino origin

Numeric

Race1

Race: first race

Numeric

Race2

Race: second race

Numeric

Education

Education (highest grade completed)

Numeric

Language

What is the primary language spoken in your home?

Numeric

WISEWOMAN MDE Manual
Edition 23.1

b. Demographic MDE Specifications
Item 3b: ResANSI*

ANSI Geographic Code of Residence
This variable indicates the ANSI geographic code of residence of the WISEWOMAN participant.

FORMAT

Type:

Character

Other Format:

N/A

Item Length:

Justification:

Left

Field Length:

Beginning Position:

Leading Zeros:

Yes

Valid Range:

Static Field:

Valid ANSI code;
cannot be blank

SOURCE

National ANSI Code List

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

ANSI Geographic Code

ANALYSIS AND USE

To assess whether programs are meeting assessment visit goals in targeted geographic areas
To identify the reach of the WISEWOMAN Program
To assist in identifying areas where there may be potential transportation barriers to accessing
WISEWOMAN services

Value representing the participant’s geographic area of residence

OTHER
INFORMATION

ANSI codes are the American National Standards Institute codes, which were developed by the
American National Standards Institute. They are five-digit codes that represent states, counties,
and statistically equivalent areas, along with American Indian and Alaska Native areas.
The first two digits of the participant ANSI geographic code of residence should represent the
state of residence for the participant, and the last three digits should represent the participant’s
county of residence.
Both ANSI geographic area of residence and ZIP code of residence (3c: ZIP) are required. ZIP
code of residence should correspond to the ANSI geographic code of residence, in that the ZIP
code must represent a valid geographic area within the county.
If a participant does not reside in the state where the program is located, the ANSI code from
their actual state of residence should be recorded.
ANSI geographic code of residence should be captured at the first assessment visit of the
submission period; if geographic code of residence changes during a submission period, the
last code collected for the submission period should be recorded.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 3c: ZIP*

ZIP Code of Residence
This variable indicates the participant’s ZIP code of residence.

FORMAT

Type:

Character

Other Format:

N/A

Item Length:

Justification:

Left

Field Length:

Beginning Position:

Leading Zeros:

Yes

Valid Range:

Static Field:

Valid Zip code;
cannot be blank

SOURCE

National ZIP Code List

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

ZIP Code of Residence

Valid five-digit (character) ZIP code

99999a

No ZIP code recorded.
This value will be flagged as an error.

ANALYSIS AND USE

To assess whether programs are meeting assessment goals in targeted geographic areas
To identify the reach of the WISEWOMAN Program
To identify participant county of residence outside program state boundaries

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
Both ANSI geographic code of residence (3b: ResANSI) and ZIP code of residence are
required. ZIP code of residence should correspond to the county code of residence, in that the
ZIP code must represent a valid geographic area within the county.
ZIP code of residence must be recorded regardless of whether the participant resides in the
same state as the program. This information will be used in conjunction with geographic code of
residence to identify the area of residence for a participant.
If a participant does not reside in the same state as the program, the ZIP code from their actual
state of residence should be recorded.
ZIP code of residence should be captured at the first assessment visit of the submission period;
if ZIP code of residence changes during a submission period, the last code collected for the
submission period should be recorded.

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 3d: MYB*

Month and Year of Birth
This variable indicates the participant’s month and year of birth.

FORMAT

Type:

Numeric

Other Format:

MMCCYY date

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Yes

Valid Range:

Static Field:

Yes

Valid date; cannot be
blank

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Month and Year of Birth

ANALYSIS AND USE

To estimate the age of the participant; age will be calculated using the month and year of birth
and office visit date
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score
To assess whether the participants are within the Program’s priority age group

Month and Year of Birth in MMCCYY format
Example: September 01, 1965 = 091965

OTHER
INFORMATION

The priority population for the WISEWOMAN Program is participants aged 35 to 64. Services
provided to participants outside the priority age range will be monitored by CDC.
Month and year of birth at the assessment visit is required for a record to count as a complete
or BP+ record. If MYB is blank, the record will not count as a complete or BP+ record, and the
record will not count toward meeting a program’s assessment goal.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 3e: Latino*

Hispanic or Latino Origin
This variable indicates whether the participant is of Hispanic or Latino origin.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Valid Range:

Static Field:

Yes

See values; cannot
be blank

SOURCE

United States Office of Management and Budget Guidelines

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Yes

Participant reports Hispanic or Latino origin.

2 No

Participant does not report Hispanic or Latino origin.

7 Unknown
9 No answer

ANALYSIS AND USE

Participant is unsure about their Hispanic or Latino origin.
recordeda

Participant has not reported whether they are of Hispanic or
Latino origin.
This value will be flagged as an error.

To assess the race/ethnicity of WISEWOMAN participants
To analyze assessments, lifestyle programs, and other variables by ethnicity
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score

aCodes and response options highlighted in gray should not appear on the data collection forms
OTHER
INFORMATION
presented to participants. They are provided for funded program use only.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 3f: Race1*

Race: First Race
This variable indicates a race with which the participant identifies.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Valid Range:

Static Field:

Yes

See values; cannot
be blank

SOURCE

United States Census Bureau; United States Office of Management and Budget Guidelines

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 White

Participant identifies White as a race.

Black or African
American

Participant identifies Black or African American as a race.

Asian

Participant identifies Asian as a race.

Native Hawaiian or
Other Pacific
Islander

Participant identifies Native Hawaiian or Other Pacific Islander as
a race.

American Indian or
Alaska Native

Participant identifies American Indian or Alaska Native as a race.

Unknown

Participant does not know their race or does not identify with any
of the races listed above.
If a participant is Hispanic and does not identify a race, this code
should be used.

No answer recordeda

Race information is missing for the participant.
Any race information gathered should be entered beginning with
the Race1 field.

ANALYSIS AND USE

To assess the race/ethnicity of WISEWOMAN participants
To understand and analyze assessments, lifestyle programs, and other variables by race
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.

If a participant identifies more than one race, one race is recorded here and another race is
recorded in the subsequent race field (3g: Race2).
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Modified Item 3f:
Race1*

Race and Ethnicity
This variable indicates a race with which the participant identifies.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Valid Range:

Static Field:

Yes

See values; cannot
be blank

SOURCE

United States Census Bureau; United States Office of Management and Budget Guidelines

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND

American Indian or

For example, Navajo Nation, Blackfeet Tribe of the Blackfeet Indian Reservation of Montana

DESCRIPTION

Alaska Native

Native Village of Barrow Inuit Traditional Government, Nome Eskimo Community, Aztec, Maya

Asian

For example, Chinese, Asian Indian, Filipino, Vietnamese, Korean, Japanese, etc.

Black or African
American
Hispanic or Latino

For example, African American, Jamaican, Haitian, Nigerian, Ethiopian, Somali, etc.

Middle Eastern or
North African

For example, Lebanese, Iranian, Egyptian, Syrian, Iraqi, Israeli, etc.

Native Hawaiian or
Other Pacific Islander

For example, Native Hawaiian, Samoan, Chamorra, Fijian, Marshallese, etc.

White

For example, English, German, Irish, Italian, Polish, Scottish, etc.

ANALYSIS AND USE

For example, Mexican, Salvadoran, Puerto Rican, Cuban, Dominican, Guatemalan, etc.

To assess the race and ethnicity of WISEWOMAN participants
To understand and analyze assessments, lifestyle programs, and other variables by race
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score

OTHER INFORMATION

WISEWOMAN MDE Manual
Edition 23.1

aCodes

and response options highlighted in gray should not appear on the data collection forms presented to participants.
They are provided for funded program use only.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 3g: Race2

Race: Second Race
This variable indicates a race with which the participant identifies in cases where a participant is
multiracial.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Valid Range:

Static Field:

Yes

See values; cannot
be blank

SOURCE

United States Census Bureau; United States Office of Management and Budget Guidelines

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

White

Participant identifies White as a race.
Participant who has identified two or more races can have this
value.

Black or African
American

Participant identifies Black or African American as a race.
Participant who has identified two or more races can have this
value.

Asian

Participant identifies Asian as a race.
Participant who has identified two or more races can have this
value.

Native Hawaiian or
Other Pacific Islander

Participant identifies Native Hawaiian or Other Pacific Islander as
a race.
Participant who has identified two or more races can have this
value.

American Indian or
Alaska Native

Participant identifies American Indian or Alaska Native as a race.
Participant who has identified two or more races can have this
value.

Unknown

Participant does not know their race or does not identify with any
of the races listed above.

9 No answer recordeda

If race information is missing for Race2
Participant has not identified any race.
Participant has identified one race and does not identify other
races.
If a participant does not identify a second race, ‘9 No answer
recorded’ should be used for this field and all subsequent race
fields.

ANALYSIS AND USE

OTHER
INFORMATION

aCodes

WISEWOMAN MDE Manual
Edition 23.1

Item 3h: Education

Education (highest grade completed)
This variable indicates the highest grade the participant completed.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Valid Range:

Static Field:

See values; cannot
be blank

SOURCE

CDC Behavioral Risk Factor Surveillance System

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 <9th grade

Participant reports that they did not attend high school.

2 Some high school

Participant reports they attended high school but did not
graduate.

3 High school graduate
or equivalent

Participant reports that they graduated from high school or have
the equivalent of a high school diploma, and they did not attend
any college or higher education.

4 Some college or
higher

Participant reports that they attended one or more years of
college and/or graduate school (e.g., college graduate, graduate
degree).

7 Don’t know/Not sure

Participant reports that they do not know the highest grade they
completed.
This value will be flagged as a quality check.

Don’t want to answera

Participant does not want to answer the highest grade they
completed.
This value will be flagged as a quality check.

No answer recordeda

Education information is missing for the participant.
This value will be flagged as an error.

ANALYSIS AND USE

To assess the educational attainment of participants in the WISEWOMAN population
To understand assessments, lifestyle programs, and other variables by education status
To help determine the literacy level needed for materials developed for recruitment, risk
reduction counseling, lifestyle programs, health coaching, and community-based resources
To assist in characterizing the population reached by the WISEWOMAN Program

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.

WISEWOMAN MDE Manual
Edition 23.1

Item 3i: Language

What is the primary language spoken in your home?
This variable indicates the primary language spoken in the participant’s home.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Yes

Valid Range:

Static Field:

Yes

See values; cannot
be blank

SOURCE

National Survey of Children’s Health

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

01 English

Participant identifies English as the primary language spoken in
their home.

02 Spanish

Participant identifies Spanish as the primary language spoken in
their home

03 Arabic

Participant identifies Arabic as the primary language spoken in
their home.

04 Chinese

Participant identifies Chinese as the primary language spoken in
their home.

05 French

Participant identifies French as the primary language spoken in
their home.

06 Italian

Participant identifies Italian as the primary language spoken in
their home.

07 Japanese

Participant identifies Japanese as the primary language spoken
in their home.

08 Korean

Participant identifies Korean as the primary language spoken in
their home.

09 Polish

Participant identifies Polish as the primary language spoken in
their home.

10 Russian

Participant identifies Russian as the primary language spoken in
their home.

11 Tagalog

Participant identifies Tagalog as the primary language spoken in
their home.

12 Vietnamese

Participant identifies Vietnamese as the primary language
spoken in their home.

13 Creole

Participant identifies Creole as the primary language spoken in
their home.

14 Portuguese

Participant identifies Portuguese as the primary language
spoken in their home.

15 Hmong

Participant identifies Hmong as the primary language spoken in
their home.

16 “

”(Write-in)

Participant identifies another language as the primary language
spoken in their home (write-in response).

88 Don’t want to answera

Participant does not want to answer the primary language
spoken in their home.
This value will be flagged as a quality check.

99 No answer recordeda

Primary language information is missing for the participant.
This value will be flagged as an error.

WISEWOMAN MDE Manual
Edition 23.1

ANALYSIS AND USE

To assess the primary language of participants in the WISEWOMAN population
To provide context to potential the health literacy issues
To assist in characterizing the population reached by the WISEWOMAN Program

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.

WISEWOMAN MDE Manual
Edition 23.1

4. HEALTH HISTORY AND MEDICATION USE MDE SPECIFICATIONS
This section provides recipients with the information necessary to support collection and
reporting of health history and medication use MDEs, which must be done according to the
specifications provided in this section of the manual.
Understanding a WISEWOMAN participant’s health history offers insights into participant’s
risk factors for cardiovascular disease and helps contextualize their results during their
baseline, follow-up, and re-assessment visits. MDEs in this section collect information about
a participant’s medical history, their medication use, and medication adherence.
For a record to be counted as a Complete or BP+ assessment, it must have valid values for
required MDEs. Definitions of complete and BP+ assessments are provided in
Appendix A.
Recipients are required to report all records, including those records that do not meet
assessment requirements, and they will be used to account for WISEWOMAN resources, but
will not be analyzed in MDE reports generated by CDC or counted toward assessment visit
goals unless additional documentation is provided.2,3
This section begins with a summary of the five required MDEs (Subsection a) and then
provides the technical specifications for each MDE (Subsection b).

2 Assessment goals are agreed upon between each recipient and CDC. The number of assessments used to assess
progress toward meeting the assessment goal is calculated as the number of records meeting minimum assessment
requirements (baseline, follow-up assessment or re-assessment).
3 If the program is unable to obtain or the participant refuses to allow measurements for height, weight, blood pressure
reading, labs, or to complete the personal assessment history, the program may choose to submit an explanation for this
situation to be considered as an acceptable screening record. See Appendix B for additional information on this process.

WISEWOMAN MDE Manual
Edition 23.1

a. Summary of Health History and Medication Use MDEs
Item
Number

Variable
Name

Beginning
Position

Variable Label

Type

SRC

Which of the following conditions do you have: i.
Hypertension, ii. High cholesterol, iii. Diabetes (Type
1 or Type 2)?

Numeric

SRHA

Have you had any of the following: i. Stroke/
transient ischemic attack (TIA), ii. Heart attack, iii.
Coronary heart disease, iv Heart failure, v. Vascular
disease (peripheral arterial disease), vi. Congenital
heart disease and defects?

Numeric

Meds

Was medication prescribed to lower: i. Blood
pressure, ii. Cholesterol (Statin), iii. Cholesterol
(other prescribed medication), iv. Blood sugar?

Numeric

Aspirin

Are you taking aspirin daily to help prevent a heart
attack or stroke?

Numeric

MedAdhere

During the past 7 days, how many days did you take
prescribed medication for the following conditions: i.
High blood pressure (0 – 7 days), ii. High cholesterol
(0 – 7 days), iii. High blood sugar (0 – 7 days)?

Numeric

WISEWOMAN MDE Manual
Edition 23.1

b. Health History and Medication Use MDE Specifications
Item 4a: SRC*

Which of the following conditions do you have:
i.
Hypertension
ii.
High cholesterol
iii.
Diabetes (Type 1 or Type 2)
This variable indicates whether the participant has hypertension, high cholesterol, and/ or
diabetes.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be blank if
TYPE is 1, 2, 3 or 4 (baseline
assessment, re-assessment, or
follow-up assessment)

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION
(CODE FOR EACH
CONDITION)

1 Yes

ANALYSIS AND USE

Participant has the condition.

2 No

Participant does not have the condition.

7 Don’t know/Not sure

Participant does not know whether they have the condition.
This value will be flagged as a quality check.

Don’t want to answera

Participant does not want to answer whether the condition.
This value will be flagged as a quality check.

No answer recordeda

No answer recorded.
This value will be flagged as an error.

To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To assess the number of cases of hypertension, high cholesterol, and diabetes that have been
previously diagnosed as opposed to newly detected cases among the WISEWOMAN population
To assess control of and improvements in blood pressure, cholesterol, and diabetes for newly
and previously diagnosed participants
To provide data elements required to determine participant’s cardiovascular risk score

OTHER
INFORMATION

Guidance
aCodes and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
Each of the three positions in the SRC field corresponds to a specific condition. The first position
aligns with the participant’s hypertension history. The second position aligns with the
participant’s high cholesterol history. The third position aligns with the participant’s diabetes
history.
Programs should assess a participant’s history for each condition and record the corresponding
value in the appropriate position in the SRC field. For example, if a participant report that they:
(a) have hypertension, (b) do not have high cholesterol, and (c) don’t know or not sure whether
they have diabetes, SRC should be recorded as ‘127’ (corresponding to values of ‘1- Yes’ in
position 1, ‘2 – No’ in position 2, and ‘7 – Don’t know/ not sure’ in position 3).
Some programs may have access to participants’ medical charts. In some cases, the medical
chart may show that a participant’s diagnosis for hypertension, high blood cholesterol, and/or
diabetes is inconsistent with their self-report. In these instances, if the medical record indicates
that they have hypertension, high blood cholesterol, and/or diabetes, the program should recode
the relevant position of SRC as ‘1 Yes.’
Hypertension, cholesterol, and diabetes history status is required for a record to count as
complete or BP+. If any position of SRC is blank or coded as ‘‘9 No answer recorded,’ the record
will not count as a complete or BP+ record, and the record will not count toward meeting a
program’s assessment goal.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 4b: SRHA*

Have you had any of the following:
i.
Stroke/ transient ischemic attack (TIA)
ii.
Heart attack
iii.
Coronary heart disease
iv.
Heart failure
v.
Vascular disease (peripheral arterial disease)
vi.
Congenital heart disease and defects
vii.
Gestational hypertension
viii.
Gestational diabetes
ix.
Pre-eclampsia/eclampsia
This variable indicates whether the participant has ever been diagnosed by a healthcare provider
as having stroke/ TIA, heart attack, coronary heart disease, heart failure, vascular disease
(peripheral arterial disease), congenital heart disease and defects, gestational hypertension,
gestational diabetes, and/or pre-eclampsia/eclampsia.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be blank if
TYPE is 1, 2, 3 or 4 (baseline
assessment, re-assessment, or
follow-up assessment)

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION
(CODE FOR EACH
CONDITION)

1 Yes

Participant has been diagnosed by a healthcare provider as
having the condition.

2 No

Participant has never been diagnosed by a healthcare provider
as having each condition.

Don’t know/Not sure

Participant does not know whether they have been diagnosed by
a healthcare provider as having the condition.
This value will be flagged as a quality check.

Don’t want to answera

Participant does not want to answer whether they have been
diagnosed by a healthcare provider as having the condition.
This value will be flagged as a quality check.

No answer recordeda

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND USE

To understand the history of cardiovascular disease among individual participants and the
overall WISEWOMAN population
To assess the number of participants who have been previously diagnosed as having
cardiovascular disease
To provide data elements required to determine participant’s cardiovascular risk

WISEWOMAN MDE Manual
Edition 23.1

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
Each of the nine positions in the SRHA field corresponds to a specific condition. The first position
aligns with the participant’s history of stroke/ TIA. The second position aligns with the
participant’s history of heart attack. The third position aligns with the participant’s history of
coronary heart disease. The fourth position aligns with the participant’s history of heart failure.
The fifth position aligns with the participant’s history of vascular disease. The sixth position aligns
with the participant’s history of congenital heart disease and defects. The seventh position aligns
with the participant’s history of gestational hypertension. The eighth position aligns with the
participant’s history of gestational diabetes. The ninth position aligns with the participant’s history
of pre-eclampsia/eclampsia.
Programs should assess a participant’s history for each condition and record the corresponding
value in the appropriate position in the SRHA field. For example, if a participant reports that they
had a stroke, but did not have heart attack, coronary heart disease, heart failure, vascular
disease (peripheral arterial disease), congenital heart disease and defects, gestational
hypertension, gestational diabetes, or pre-eclampsia/eclampsia, then SRHA should be recorded
as ‘122222222’ (corresponding to values of ‘1- Yes’ in position 1 and ‘2 – No’ in position 2
through position 9).

OTHER
INFORMATION
(CONT.)

Some programs may have access to participants’ medical charts. In some cases, the medical
chart may show that a participant’s diagnosis for one of the specified conditions is inconsistent
with their self-report. In these instances, if the medical record indicates that they have any one of
these conditions, the program should recode the corresponding position of SRHA as ‘1 Yes.’
History of each of the nine conditions is required for a record to count as a complete or BP+
record. If any position of SRHA is blank or coded as ‘’9 No answer recorded,’ the record will not
count as a complete or BP+ record, and the record will not count toward meeting a program’s
assessment goal.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 5a: Meds*

Was medication prescribed to lower:
i.
Blood pressure
ii.
Cholesterol (Statin)
iii.
Cholesterol (other prescribed medication)
iv.
Blood sugar
This variable indicates whether the participant was prescribed medication to lower their blood
pressure, cholesterol, and/or blood sugar.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Valid Range:

Static Field:

See values; cannot
be blank

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with hypertension (high blood pressure),
high cholesterol, or diabetes or participants who were previously diagnosed with hypertension
(high blood pressure), high cholesterol, or diabetes.

VALUES AND
DESCRIPTION
(CODE FOR EACH
CONDITION)

Yes

5 Not

Participant was prescribed medication for the condition.
Participant was not prescribed medication for the condition.
Applicablea

This question is not applicable for the patient because they have
never been diagnosed with for the condition, either because they
do not have the condition (as assessed with a measurement at
baseline assessment/ re-assessment) or because they report
that they have never been diagnosed with the condition (as
assessed with self-report at baseline assessment / reassessment).

Don’t know/Not sure

Participant does not know whether they were prescribed
medication for the condition.
This value will be flagged as a quality check.

Don’t want to answera

Participant does not want to answer whether they were
prescribed medication for the condition.
This value will be flagged as a quality check.

No answer recordeda

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND USE

To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To assess the number of cases of hypertension, high cholesterol, and diabetes that have been
previously diagnosed as opposed to newly detected cases among the WISEWOMAN population
To assess the control and management of blood pressure, cholesterol, and diabetes among
participants who have hypertension, high cholesterol, or diabetes
To assist in assessment of adherence to medication for hypertension, high cholesterol, and
diabetes
To provide data element required to determine participant’s ASCVD risk

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
Each of the four positions in the Meds field corresponds to use of a condition-specific type of
medication. The first position aligns with use of blood pressure medication. The second position
aligns with use of statins for high cholesterol. The third position aligns with use of other
medication (besides statins) for high cholesterol. The fourth position aligns with use of
medication for diabetes.

WISEWOMAN MDE Manual
Edition 23.1

OTHER
INFORMATION
(CONT.)

Programs should assess a participant’s prescribed medication status for each condition and
record the corresponding value in the appropriate position in the Meds field. For example, if a
participant reports that they: (a) have hypertension and have not been prescribed blood
pressure medication, (b) do not have high cholesterol and were not prescribed statins, (c) do
not have high cholesterol and were not prescribed other cholesterol medication, and (d) have
diabetes and were prescribed blood sugar medication, Meds should be recorded as ‘2551’
(corresponding to values of ‘2 – No’ in position 1, ‘5 – Not applicable’ in position 2, ‘5 – Not
applicable’ in position 3, and ‘1 – Yes’ in position 4).
If a participant reports that they do not know whether they were prescribed medication for one of
these conditions or doesn’t want to answer whether they were prescribed medication for one of
these conditions, programs should have a discussion with them to verify the response.
Medication prescription status at baseline assessment is required for a record to count as a
complete or BP+ record. If Meds is blank or coded as ‘‘9 No answer recorded,’ the record will
not count as a complete or BP+ record, which means the record will not count toward meeting a
program’s assessment goal.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 5b: Aspirin*

Are you taking aspirin daily to help prevent a heart attack or stroke?
This variable indicates whether the participant is taking aspirin daily to help prevent a heart
attack or stroke.

FORMAT

Type:

Numeric

Other Format:

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be
blank

N/A

SOURCE

American College of Cardiology

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Yes

Participant is taking aspirin daily to help prevent a heart attack or
stroke.

2 No

Participant is not taking aspirin daily to help prevent a heart
attack or stroke.

Don’t know/Not sure

Participant does not know whether they are taking aspirin daily to
help prevent a heart attack or stroke.
This value will be flagged as a quality check.

Don’t want to answera

Participant does not want to answer whether they are taking
aspirin daily to help prevent a heart attack or stroke.
This value will be flagged as a quality check.

No answer recordeda

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND USE

To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
If a participant reports that they do not know whether they are taking aspirin or do not want to
answer whether they are taking aspirin, programs should have a discussion with them to verify
the response.
Use of aspirin at assessments is required for a record to count as a complete or BP+ record. If
Aspirin is blank or coded as ‘‘9 No answer recorded,’ the record will not count as a complete or
BP+ record, which means the record will not count toward meeting a program’s assessment
goal.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 5c: MedAdhere*

During the past 7 days, how many days did you take prescribed medication for the
following conditions:
i.
High blood pressure (0 – 7 days)
ii.
High cholesterol (0 – 7 days)
iii.
High blood sugar (0 – 7 days)
This variable indicates the number of days out of the past 7 days, including the day of the
assessment, that the participant took prescribed medication to lower their blood pressure,
cholesterol, and/or blood sugar.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Yes

Valid Range:

Static Field:

See values; cannot be
blank

SOURCE

Adapted from National Survey of Children’s Health

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants taking medication to lower blood
pressure, cholesterol, or blood sugar.

VALUES AND
DESCRIPTION
(CODE FOR EACH
CONDITION)

Number of days (01-07)

A numeric value indicating the number of days out of the past 7
days, including the day of the assessment, that the participant
took prescribed medication for the condition.
Any value outside the valid range (01 – 07) will be considered an
error.

00 None

In the past 7 days, including the day of the assessment, the
participant did not take prescribed medication for the condition.

55 Not Applicablea

This question is not applicable for the patient because they have
never been diagnosed with the condition (high blood pressure,
high cholesterol, or high blood sugar) and/or has indicated that
they do not take medication for the condition.

77 Don’t know/Not sure

Participant is not sure whether they took prescribed medication to
lower their cholesterol during the past 7 days including the day of
the assessment.
This value will be flagged as a quality check.

88 Don’t want to answera

Participant did not want to answer whether they took prescribed
medication for the condition during the past 7 days, including the
day of the assessment.
This value will be flagged as a quality check.
No answer recorded
This value will be flagged as an error.

99 No answer recordeda
ANALYSIS AND USE

To facilitate assessment of adherence to medication prescribed for high blood pressure, high
cholesterol, and diabetes
To assist in determining management and control for high blood pressure, high cholesterol, and
diabetes

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
Each of the three positions in the MedAdhere field corresponds with the number of days taking
medication for a specific condition in the past week. The first position aligns with the number of
days taking medication for hypertension. The second position aligns with the number of days
taking medication for high cholesterol. The third position aligns with the number of days taking
medication for high blood sugar.

OTHER
INFORMATION
(CONT.)

Programs should assess the number of days a participant took prescribed medication for each
condition and record the corresponding value in the appropriate position of 5c: MedAdhere. For
example, if a participant reports that they: (a) have never been diagnosed with hypertension and
have not been prescribed blood pressure medication, (b) were prescribed medication for high
cholesterol and take medication 7 day per week, and (c) have diabetes and were prescribed
medication for blood sugar, but do not take this medication ever, MedAdhere should be
recorded as ‘550700’ (corresponding to values of ‘55 – Not applicable’ in position 1, ‘07 – 7
days per week’ in position 2, and ‘00 – None’ in position 3).

WISEWOMAN MDE Manual
Edition 23.1

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

5. BEHAVIORAL MDE SPECIFICATIONS
This section provides recipients with the information necessary to support collection and
reporting of behavioral MDEs, which must be done according to the specifications provided in
this section of the manual.
This section collects information around participant's health behaviors related to known
cardiovascular disease risk factors. MDEs in this section collect information regarding
participant’s self-measurement of blood pressure, nutrition, physical activity, smoking status,
alcohol consumption, and mental well-being.
For a record to be counted as a Complete or BP+ assessment, it must have valid values for
required MDEs. Definitions of complete and BP+ assessments are provided in
Appendix A.
Recipients are required to report all records, including those records that do not meet
assessment requirements. These records are used to account for WISEWOMAN resources
but are not analyzed in MDE reports generated by CDC or counted toward assessment visit
goals unless additional documentation is provided.2,3
This section begins with a summary of the 14 MDEs (Subsection a) and provides the
technical specifications for each MDE (Subsection b).

WISEWOMAN MDE Manual
Edition 23.1

Blank Page

This Page Has Been Left Blank Intentionally

WISEWOMAN MDE Manual
Edition 23.1

a. Summary of Behavioral MDEs
Item
Number

Variable
Name

Beginning
Position

Variable Label

Type

Monitored

After being prescribed medication, on what date(s)
did the participant have their blood pressure remeasured either by a healthcare provider, or with
another community resource?

Numeric

BPHome

111

Do you measure your blood pressure at home or
using other calibrated sources?

Numeric

BPFreq

112

How often do you measure your blood pressure at
home or using other calibrated sources?

Numeric

BPSend

113

Do you regularly share blood pressure readings with
a health care provider for feedback?

Numeric

FruitVeg

114

How many cups of fruits and vegetables do you eat
in an average day?

Numeric

Fish

116

Do you eat fish at least two times a week?

Numeric

Grains

117

Thinking about all the servings of grain products you
eat in a typical day; how many are whole grains?

Numeric

Sugar

118

Do you drink less than 36 ounces (450 calories) of
beverages with added sugars weekly?

Numeric

SaltWatch

119

Are you currently watching or reducing your sodium
or salt intake?

Numeric

AlcFreq

120

In the past 7 days, how often do you have a drink
containing alcohol?

Numeric

AlcDay

122

How many alcoholic drinks, on average, do you
consume during a day you drink?

Numeric

124

How many minutes of physical activity (exercise) do
you get in a week?

Numeric

Smoker

128

Do you smoke? Includes cigarettes, pipes, or cigars
(smoked tobacco in any form)

Numeric

10a

PHQ

129

Numeric

WISEWOMAN MDE Manual
Edition 23.1

b. Behavioral MDE Specifications
Item 5d: Monitored

After being prescribed medication, on what date(s) did the participant have their blood
pressure re-measured either by a healthcare provider, or with another community
resource?
This variable indicates the date when blood pressure is re-measured for a participant who is
prescribed blood pressure medication, which is often related to titration of prescribed blood
pressure medications.

FORMAT

Type:

Numeric

Other Format:

MMDDCCYY

Item Length:

Justification:

Right

Field Length:

Beginning Position:

Leading Zeros:

Yes

Valid Range:

Valid date

Static Field:

SOURCE

WISEWOMAN-specific optional variable for blood pressure follow-up

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants taking medication to lower blood
pressure.

VALUES AND
DESCRIPTION

Blood Pressure
Monitoring Dates

ANALYSIS AND USE

To assist in determining management and control for high blood pressure

OTHER
INFORMATION

This is an optional recipient use field. If systolic blood pressure re-measurements are
recorded in 12b: SBP (positions 4 through 12) or diastolic blood pressure re-measurements are
recorded in 12c: DBP (positions 4 through 12), programs should document the date of the blood
pressure re-measurement in the Monitored field.
The position of the re-measurement date in Monitored should correspond with the position of
the blood pressure re-measurement in SBP and DBP. For example, the first systolic blood
pressure re-measurement should be entered in positions 4 through 6 of SBP, the first diastolic
blood pressure re-measurement should be entered in positions 4 through 6 of DBP, and the
date of the first blood pressure re-measurement should be recorded in positions 1 through 8 of
Monitored. If another re-measurement is obtained after the assessment date and prior to a
subsequent follow-up assessment or re-assessment, the second systolic blood pressure remeasurement should be recorded in positions 7 through 9 of SBP, the second diastolic blood
pressure re-measurement should be recorded in position 7 through 9 of DBP, and the remeasurement date associated with the second blood pressure re-measurement should be
recorded in position 9 through 16 of Monitored.
Programs can submit up to three blood pressure re-measurements and re-measurement dates.
If one or more SBP re-measurements or DBP re-measurements are recorded, then a date must
accompany it in Monitored (MDE 5d).

WISEWOMAN MDE Manual
Edition 23.1

Valid date in MMDDCCYY format
Date when blood pressure is re-measured by a health care
provider or another community resource.
Example: December 01, 2023 = 12012023

Item 6a: BPHome

Do you measure your blood pressure at home or using other calibrated sources (outside
the home)?
This variable indicates whether the participant monitors their blood pressure at home or using
other calibrated sources (select the best option).

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

111

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be
blank

SOURCE

HealthStyles Survey

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with high blood pressure or previously
diagnosed with hypertension (high blood pressure).

VALUES AND
DESCRIPTION

1 Yes

Participant reports that they measure their blood pressure at
home or using other calibrated sources (outside the home).

No – Was never told
to measure their
blood pressure

Participant reports that they do not measure their blood pressure
at home or using other calibrated sources (outside the home)
because they were never told they should measure their blood
pressure.

No – Doesn’t know
how to measure their
blood pressure

Participant reports that they do not measure their blood pressure
at home or using other calibrated sources (outside the home)
because they do not know how to measure their blood pressure.

No – Doesn’t have
equipment to measure
their blood pressure

Participant reports that they do not measure their blood pressure
at home or using other calibrated sources (outside the home)
because they do not have access to the required equipment to
measure their blood pressure.

Not Applicablea

This question is not applicable for the patient because they have
never been diagnosed with hypertension (high blood pressure).

Don’t know/Not
sure/Other

Participant is not sure whether they measure their blood pressure
at home or using other calibrated sources (outside the home) or
provides some other reason for why they do not measure their
blood pressure at home (for example, participant chooses not to
measure their blood at home).
This value will be flagged as a quality check.

Don’t want to answera

Participant did not want to answer whether they measure their
blood pressure at home or using other calibrated sources
(outside the home).
This value will be flagged as a quality check.

No answer recordeda

No answer recorded
This value will be flagged as an error.

ANALYSIS AND USE

To determine self-control and management of hypertension (high blood pressure)

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
Participants should select one response that is the best option.
Guidance on blood pressure self-monitoring is available in the Self-Measured Blood Pressure
Monitoring Guide by Million Hearts (Centers for Disease Control and Prevention. Self-Measured
Blood Pressure Monitoring: Action Steps for Public Health Practitioners. Atlanta, GA: Centers
for Disease Control and Prevention, US Dept. of Health and Human Services; 2013.)

WISEWOMAN MDE Manual
Edition 23.1

Item 6b: BPFreq

How often do you measure your blood pressure at home or using other calibrated
sources (outside the home)?
This variable indicates how frequently the participant measures their blood pressure at home or
uses other calibrated sources (outside the home).

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

112

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be
blank

SOURCE

HealthStyles Survey

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with high blood pressure or previously
diagnosed with hypertension (high blood pressure).

VALUES AND
DESCRIPTION

Multiple times per day

Participant measures their blood pressure at home or using other
calibrated sources (outside the home) multiple times per day.

2 Daily

Participant measures their blood pressure at home or using other
calibrated sources (outside the home) once per day.

A few times per week

Participant measures their blood pressure at home or using other
calibrated sources (outside the home) a few times per week.

Weekly

Participant measures their blood pressure at home or using other
calibrated sources (outside the home) once per week.

Monthly

Participant measures their blood pressure at home or using other
calibrated sources (outside the home) once per month.

Not Applicablea

This question is not applicable for the patient because they have
never been diagnosed with hypertension (high blood pressure) or
do not monitor their blood pressure at home or using other
calibrated sources (outside the home).

Don’t know/Not
sure/Other

Participant is not sure how frequently they measure their blood
pressure at home or using other calibrated sources (outside the
home).
This value will be flagged as a quality check.

Don’t want to answera

Participant did not want to answer how frequently they measure
their blood pressure at home or using other calibrated sources
(outside the home).
This value will be flagged as a quality check.

No answer recordeda

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND USE

To determine self-control and management of hypertension (high blood pressure)

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.

WISEWOMAN MDE Manual
Edition 23.1

Item 6c: BPSend

Do you regularly share blood pressure readings with a health care provider for
feedback?
This variable indicates whether the participant shares blood pressure readings, taken at home
or from using other calibrated sources (outside the home), with a health care provider for
feedback almost every time they see their provider.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

113

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be
blank

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with high blood pressure or previously
diagnosed with hypertension (high blood pressure).

VALUES AND
DESCRIPTION

1 Yes

Participant reports that they regularly share blood pressure
readings, taken at home or from using other calibrated sources
(outside the home), with a health care provider for feedback
almost every time they see their provider.

2 No

Participant reports that they do not regularly share blood
pressure readings, taken at home or from using other calibrated
sources (outside the home), with a health care provider for
feedback.

5 Not Applicablea

Don’t know/Not
sure/Other

Participant is not sure whether they share blood pressure
readings, taken at home or from using other calibrated sources
(outside the home), with a health care provider for feedback.
This value will be flagged as a quality check.

Don’t want to answera

Participant did not want to answer whether they share blood
pressure readings, taken at home or from using other calibrated
sources (outside the home), with a health care provider for
feedback.
This value will be flagged as a quality check.

No answer recordeda

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND USE

To determine self-control and management of hypertension (high blood pressure)
To determine whether blood pressure monitoring results are shared with a health care provider
for monitoring of progress

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.

WISEWOMAN MDE Manual
Edition 23.1

Item 7a: FruitVeg*

How many cups of fruits and vegetables do you eat in an average day?
This variable indicates the amount of fruit and vegetables the participant consumes in an
average day.

FORMAT

Type:

Numeric

Other Format:

Item Length:

Justification:

Right

Field Length:

Beginning Position:

114

Leading Zeros:

Yes

Valid Range:

01-65; cannot be blank

Static Field:

N/A

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Number of cups

Two-digit (numeric) value representing the number of cups of fruit
and vegetables the participant consumes in an average day
Any value outside the valid range (01 -65) will be considered an
error
Example: 2 cups = 02

00 None

Participant does not consume fruit or vegetables in an average
day.

88 Don’t want to answera

Participant does not want to answer how many cups of fruit and
vegetables they consume in an average day.
This value will be flagged as a quality check.

99 No answer recordeda

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND USE

To determine the healthy behaviors and CVD risk factors of individual participants and the
overall WISEWOMAN population
To provide data elements required to determine participant’s cardiovascular risk

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
Examples of one cup of fruit and vegetables sourced from the American Heart Association’s
Life’s Simple Seven provided in Appendix E.
Average fruit and vegetable consumption at assessment is required for a record to count as a
complete record. If FruitVeg is blank, coded as ‘‘99 No answer recorded,’ or outside of the valid
range (1-65 cups) the record will not count as a complete record.

*Complete records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 7b: Fish*

Do you eat fish at least two times a week?
This variable indicates whether the participant consumes two servings or more of fish weekly.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

116

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be
blank

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Yes

Participant consumes two servings or more of fish weekly.

Participant does not consume two servings or more of fish weekly.

8 Don’t want to
answera

Participant does not want to answer whether they consume two
servings or more of fish weekly.
This value will be flagged as a quality check.

9 No answer recordeda

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND USE

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
Examples of servings of fish sourced from the American Heart Association’s Life’s Simple
Seven provided in Appendix E.
Average fish consumption at assessment is required for a record to count as a complete record.
If Fish is blank or coded as ‘‘9 No answer recorded,’ the record will not count as a complete
record.

*Complete records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 7c: Grains*

Thinking about all the servings of grain products you eat in a typical day; how many are
whole grains?
This variable indicates the relative amount of whole grains the participant consumes compared
to the total amount of grains consumed in a typical day.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

117

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be
blank

SOURCE

United States Department of Agriculture

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Less than half

Less than half of servings of grain products consumed in a typical
day are whole grains.

About half

About half of servings of grain products consumed in a typical
day are whole grains.

3 More than half

More than half of servings of grain products consumed in a
typical day are whole grains.

Don’t want to answera

Participant does not want to answer how many servings of grain
products consumed in a typical day are whole grains.
This value will be flagged as a quality check.

No answer recordeda

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND USE

To determine the healthy behaviors and CVD risk factors of individual participants and the
overall WISEWOMAN population and provide data elements required to determine participant’s
cardiovascular risk

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
Examples of servings of whole grains sourced from the American Heart Association’s Life’s
Simple Seven provided in Appendix E.
Average whole grain consumption at assessment is required for a record to count as a complete
record. If Grains is blank or coded as ‘‘9 No answer recorded,’ the record will not count as a
complete record.
*Complete records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 7d: Sugar*

Do you drink less than 36 ounces (450 calories) of sugar sweetened beverages weekly?
This variable indicates whether the participant drinks less than 36 ounces (450 calories) of
sugar sweetened beverages weekly.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

118

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be
blank

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Yes

Participant consumes less than 36 ounces (450 calories) of
beverages with added sugars in an average week.

2 No

Participant consumes 36 ounces or more (450 calories or more)
of beverages with added sugars in an average week.

Don’t want to answera

Participant does not want to answer whether they consume less
than 36 ounces (450 calories) or more of beverages with added
sugars in an average week.
This value will be flagged as a quality check.

No answer recordeda

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND USE

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
Examples of 36 ounces of beverages with added sugars sourced from the American Heart
Association’s Life’s Simple Seven provided in Appendix E.
Average sugar-sweetened beverage consumption at assessment is required for a record to
count as a complete record. If Sugar is blank or coded as ‘‘9 No answer recorded,’ the record
will not count as a complete record.
*Complete records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 7e: SaltWatch*

Are you currently watching or reducing your sodium or salt intake?
This variable indicates whether the participant is currently watching or reducing their sodium or
salt intake.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

119

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be
blank

SOURCE

CDC Behavioral Risk Factor Surveillance System

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Yes

Participant is currently watching or reducing their sodium or salt
intake.

2 No

Participant is not currently watching or reducing their sodium or
salt intake.

Don’t want to answera

Participant does not want to answer whether they are currently
watching or reducing their sodium or salt intake.
This value will be flagged as a quality check.

No answer recordeda

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND USE

To determine the healthy behaviors and CVD risk factors of individual participants and the
overall WISEWOMAN population

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
Whether a participant is watching their sodium intake at assessment is required for a record to
count as a complete record. If Saltwatch is blank or coded as ‘‘9 No answer recorded,’ the
record will not count as a complete record.
*Complete records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 7f: AlcFreq

In the past 7 days, how often do you have a drink containing alcohol?
This variable indicates the number of days during the past 7 days that a participant had a drink
containing alcohol.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

120

Leading Zeros:

Yes

Valid Range:

Static Field:

See values; cannot be
blank

SOURCE

Alcohol Use Disorders Identification Test

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Number of days

A two-digit (numeric) value representing the number of days
during the past 7 days that the participant consumed a drink that
contained alcohol. Any value outside the valid range (00-07) will
be considered a quality check.
Example: 4 days = 04

00 None

Participant has not consumed any drinks containing alcohol
during the past 7 days.

88 Don’t want to answera

Participant does not want to answer how many days during the
past 7 days they have consumed drinks containing alcohol.
This value will be flagged as a quality check.

99 No answer recordeda

No answer recorded.
This value will be flagged as a quality check.

ANALYSIS AND USE

To determine the healthy behaviors and CVD risk factors of individual participants and the
overall WISEWOMAN population

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.

WISEWOMAN MDE Manual
Edition 23.1

Item 7g: AlcDay

How many alcoholic drinks, on average, do you consume during a day you drink?
This variable indicates the average number of alcoholic drinks consumed during a day.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

122

Leading Zeros:

Yes

Valid Range:

Static Field:

See values; cannot
be blank

SOURCE

Alcohol Use Disorders Identification Test

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Number of drinks

A numeric value indicating the average number of alcoholic
drinks consumed during a day when the participant is
drinking alcohol.
Any value outside the valid range (00 – 50) will be
considered a quality check.

00 None

The participant does not consume any alcoholic drinks.

88 Don’t want to answera

Participant did not want to answer the average number of
alcoholic drinks they consume during a day when they are
drinking alcohol.
This value will be flagged as a quality check.

99 No answer recordeda

No answer recorded.
This value will be flagged as a quality check.

ANALYSIS AND USE

To determine the healthy and risky behaviors and CVD risk factors of individual participants and
the overall WISEWOMAN population

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
A standard alcoholic drink is defined in Appendix E and as the follows: 12 fluid ounces of beer
(about 5% alcohol), 8-9 fluid ounces of malt liquor (about 7% alcohol), 5 fluid ounces of wine
(about 12% alcohol), or a 1.5 fluid ounce shot of 80 proof spirits (e.g., vodka, rum, gin, whiskey,
tequila; about 40% alcohol).

WISEWOMAN MDE Manual
Edition 23.1

Item 8a: PA*

How many minutes of physical activity (exercise) do you get in a week?
This variable indicates the amount of physical activity the participant gets during an average
week.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

124

Leading Zeros:

Yes

Valid Range:

Static Field:

010-1700; cannot be
blank

SOURCE

American Heart Association Life’s

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Number of minutes

A four-digit (numeric) value representing the minutes of physical
activity the participant gets during an average week
Any value outside the valid range (0010 – 1700) will be considered a
quality check.
Example: 30 minutes = 0030
If the number of minutes of physical activity exceeds 1700 minutes,
PA should be coded as 1700 and the number of minutes of physical
activity should be documented using the Validation of Data form. See
Appendix B for the procedure for validating out-of-range values.

0000 None

Participant does not get any physical activity during an average week.

8888 Don’t want to
answera

Participant does not want to answer how much physical activity they
get during an average week.
This value will be flagged as a quality check.

9999 No answer
recordeda

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND USE

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
Examples of physical activity sourced from the American Heart Association’s Life’s Simple
Seven provided in Appendix E.
Average physical activity at assessment is required for a record to count as a complete record.
If PA is blank or coded as ‘‘9999 No answer recorded,’ the record will not count as a complete
record.
*Complete records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 9a: Smoker*

Do you smoke? Includes cigarettes, pipes, or cigars (smoked tobacco in any form)
This variable indicates whether the participant smokes tobacco in any form, including cigarettes,
pipes, or cigars.

FORMAT

Type:

Numeric

Item Length:

Justification:

Right

Field Length:

Beginning Position:

128

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be
blank

Other Format:

N/A

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Current Smoker

Participant currently smokes tobacco in any form, including
cigarettes, pipes, or cigars.

Quit (1-12 months ago)

Participant quit smoking tobacco in any form, including cigarettes,
pipes, or cigars, 1 to 12 months ago.

Quit (More than 12
months ago)

Participant quit smoking tobacco in any form, including cigarettes,
pipes, or cigars, more than 12 months ago.

4 Never Smoked

Participant has never smoked tobacco in any form, including
cigarettes, pipes, or cigars.

Don’t want to answera

Participant does not want to answer whether they smoke tobacco
in any form, including cigarettes, pipes, or cigars.
This value will be flagged as a quality check.

No answer recordeda

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND
USE

To determine the healthy behaviors and CVD risk factors of individual participants and the overall
WISEWOMAN population
To identify participants who might benefit from smoking cessation counseling and tobacco
cessation resources (quit line and community-based)
To provide data elements required to determine participant’s ASCVD risk

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
presented to participants. They are provided for funded program use only.
Smoking status at assessment is required for a record to count as a complete or BP+ record. If
Smoker is blank or coded as ‘‘9 No answer recorded,’ the record will not count as a complete or
BP+ record, which means the record will not count toward meeting a program’s assessment goal.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 10a: PHQ*

Over the past 2 weeks, how often have you been bothered by any of the following
problems?
i.
Little interest or pleasure in doing things (not at all, several days, more than half,
or nearly every day)?
ii.
Feeling down, depressed, or hopeless (not at all, several days, more than half, or
nearly every day)?
This variable indicates the number of days during the past two weeks that the participant felt little
interest or pleasure in doing things and felt down, depressed, or hopeless.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

129

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be
blank

SOURCE

Patient Health Questionnaire (PHQ-2)

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION
(CODE FOR EACH
ISSUE)

0 Not at all

Participant has not been bothered by this issue at all over the past
two weeks.

1 Several days

Participant has been bothered by this issue several days over the
past two weeks.

2 More than half

Participant has been bothered by this issue more than half the
days over the past two weeks.

3 Nearly every day

Participant has been bothered by this issue nearly every day over
the past two weeks.

Don’t want to answera

Participant does not want to answer how often they have been
bothered by this issue.
This value will be flagged as a quality check.

No answer recordeda

No answer recorded.
This value will be flagged as an error.

ANALYSIS AND
USE

To determine the health status of individual participants and the overall WISEWOMAN population
To provide health status information for cost benefit or cost effectiveness analyses

OTHER
INFORMATION

WISEWOMAN MDE Manual
Edition 23.1

6. CLINICAL VALUE MDE SPECIFICATIONS
This section provides recipients with the information necessary to support collection and
reporting of clinical value MDEs, which must be done according to the specifications provided
in this section of the manual.
These MDEs collect clinical measurement values during participant’s assessment visits. They
provide reliable benchmarks for measuring participant progress throughout the program.
MDEs in this section include blood pressure, cholesterol, blood sugar, height, weight, and
waist measurements.
For a record to be counted as a Complete or BP+ assessment, it must have valid values for
required MDEs. Definitions of complete and BP+ assessments are provided in
Appendix A.
Recipients are required to report all records, including those records that do not meet
assessment requirements, and they will be used to account for WISEWOMAN resources, but
will not be analyzed in MDE reports generated by CDC or counted toward assessment visit
goals unless additional documentation is provided.2,3
This section begins with a summary of the 15 MDEs (Subsection a) and then provides the
technical specifications for each MDE (Subsection b).

WISEWOMAN MDE Manual
Edition 23.1

a. Summary of Clinical Value MDEs
Item
Number
11a

Variable
Name
Height

Beginning
Position
131

Variable Label

Type

Height, inches

Numeric

11b

Weight

133

Weight, pounds

Numeric

11c

Waist

136

Waist circumference, inches

Numeric

12a

BPDate

138

Clinical assessment date (office visit date)

Numeric

12b

SBP

146

Systolic blood pressure, mmHg

Numeric

12c

DBP

158

Diastolic blood pressure, mmHg

Numeric

13a

Fast

170

Fasting status

Numeric

14a

TotChol

171

Total cholesterol (fasting or nonfasting), mg/dL

Numeric

14b

HDL

174

HDL cholesterol (fasting or nonfasting), mg/dL

Numeric

14c

LDL

177

LDL cholesterol (fasting or nonfasting), mg/dL

Numeric

14d

Trigly

180

Triglycerides (fasting or nonfasting), mg/dL

Numeric

15a

Glucose

184

Glucose (fasting only), mg/dL

Numeric

15c

A1C

187

A1C percentage

Numeric

16a

BPAlert

191

Is a medical follow-up for blood pressure reading
necessary?

Numeric

16b

BPDiDate

192

What is the date of the medically necessary followup appointment?

Numeric

WISEWOMAN MDE Manual
Edition 23.1

b. Clinical Values MDE Specifications
Item 11a: Height*

Height
This variable indicates the participant’s height in inches at baseline assessment.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

131

Leading
Zeros:

Valid Range:

Static Field:

Yes

48-76; cannot be blank if TYPE is
1, 2, 3 or 4 (baseline
assessment, re-assessment, or
follow-up assessment)

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Height in inches

Up to a two-digit (numeric) value representing the participant’s
height at baseline assessment
Height values between 48" and 58" or 74" and 76" will be flagged
for quality checks and program verification. See Appendix B for
the procedure for validating out-of-range values. Any values
outside 48"-76" will be considered an error.
Example: 62" (5 feet, 2 inches) = 62

77 Unable to obtain

Height measurement was attempted, but measurement results
were not obtained. See Appendix B for the procedure for
documenting the reason that the measurement was not obtained.
This value will be flagged as an error.

88 Client refuseda

Participant refuses to have their height measurement taken.
This value will be flagged as an error.

99 No measurement
recordeda

Height measurement was not performed.
This value will be flagged as an error.

ANALYSIS AND USE

To calculate the BMI of WISEWOMAN participants
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To provide data elements required to determine participant’s cardiovascular risk

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
All height measurements should be recorded in inches.
Height measurement at assessment is required for a record to count as a complete or BP+
record. If Height is blank or coded as ‘777 Unable to obtain,’ ‘888 Client refused,’ or ‘999 No
measurement recorded,’ or is outside of the valid range (48-76 inches) the record will not count
as a complete or BP+ record, and the record will not count toward meeting a program’s
assessment goal. If exceptional circumstances do not allow height measurement, these reasons
should be documented in the Validation of Data form as instructed in Appendix B.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 11b: Weight*

Weight
This variable indicates the participant’s weight in pounds.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

133

Leading
Zeros:

Yes

Valid Range:

Static Field:

074-460; cannot be blank if TYPE
is 1, 2, 3 or 4 (baseline
assessment, re-assessment, or
follow-up)

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Weight in pounds

Up to a three-digit (numeric) value representing the participant’s
weight
Weight values between 74 and 90 lbs. or 350 and 460 lbs. will be
flagged for quality checks and program verification. See Appendix B
for the procedure for validating out-of-range values. Any values
outside 74-460 lbs. will be considered an error.
Example: 98 lbs. = 098

777 Unable to obtain

Weight measurement was attempted, but measurement results were
not obtained.
This value will be flagged as a quality check. See Appendix B for the
procedure for documenting the reason that the measurement was
not obtained.

888 Client refuseda

Participant refuses to have their weight measurement taken.
This value will be flagged as a quality check.

999 No measurement
recordeda

Weight measurement was not performed.
This value will be flagged as an error.

ANALYSIS AND USE

To calculate the BMI of WISEWOMAN participants
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection
forms completed by the provider. They are provided for funded program use only.
Weight measurement at assessment is required for a record to count as a complete or BP+
record. If Weight is blank or coded as ‘999 No measurement recorded,’ or is outside of the
valid range (74-460 lbs.) the record will not count as a complete or BP+ record, and the
record will not count toward meeting a program’s assessment goal. If exceptional
circumstances do not allow weight measurement, these reasons should be documented in
the Validation of Data form, as instructed in Appendix B.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 11c: Waist

Waist Circumference
This variable indicates the participant’s waist circumference in inches.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

136

Leading Zeros:

Valid Range:

16-71

Static Field:

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Waist Circumference in
inches

Up to a two-digit (numeric) value representing the participant’s
waist circumference in inches
Any value outside the valid range (16 – 71 inches) will be flagged
as a quality check.
Example: 30 inches = 30

77 Unable to obtain

Waist circumference measurement was attempted, but
measurement results were not obtained.

88 Client refuseda

Participant refuses to have their waist circumference
measurement taken.

99 No measurement
recordeda

Waist circumference measurement was not performed.

ANALYSIS AND USE

To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.

WISEWOMAN MDE Manual
Edition 23.1

Item 12a: BPDate*

Clinical Assessment Date (Office Visit Date)
This variable indicates the date of the office visit for a participant.

FORMAT

Type:

Numeric

Other Format:

MMDDCCYY

Item Length:

Justification:

Right

Field Length:

Beginning Position:

138

Leading Zeros:

Yes

Valid Range:

Valid date

Static Field:

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Clinical assessment
date/Office visit date

ANALYSIS AND USE

To identify the date of the assessment office visit
To facilitate analysis of changes in blood pressure over time
To calculate other service time frames, including time to re-assessment, lifestyle program
sessions, lifestyle program/health coaching follow-up assessment, risk reduction counseling
sessions, alert referrals, and labs

OTHER
INFORMATION

Clinical assessment date should be used to indicate the date that the assessment visit
occurred.
If BPDate is missing or invalid, the record will not count as a complete or BP+ record, and the
record will not count toward meeting a program’s assessment goal.
Since all assessment measurements and assessments are to be used to determine
participation in the lifestyle programs and health coaching, it is expected that all labs and other
assessment services will be completed within as short a time frame as possible. Thirty days is
the recommended time frame in which blood pressure measurements should be done prior to or
after the clinical assessment date unless specified by the program’s medical advisory group or
medical clinic.

Valid date in MMDDCCYY format
Date of the office visit for a participant
Example: December 01, 2023 = 12012023

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 12b: SBP*

Systolic Blood Pressure
This variable indicates the participant’s systolic blood pressure readings.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

146

Leading Zeros:

Yes

Valid Range:

Static Field:

074-260; cannot be blank if TYPE
is 1, 2, 3 or 4 (baseline
assessment, re-assessment, or
follow-up assessment)

SOURCE

Not applicable; health assessment measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION
(CODE FOR EACH
READING AND IN
THE ORDER TAKEN)

Systolic blood pressure
in mmHg

A three-digit (numeric) value representing the participant’s
systolic blood pressure in mmHg
Systolic blood pressure values between 230 and 260 mmHg will
be flagged for quality checks and program verification. Values
outside 74-260 mmHg will be flagged as errors. See Appendix B
for the procedure for validating out-of-range values.
If a blood pressure measurement was not obtained at the time of
the office visit and obtained at a referral visit within 30 days of the
visit, the blood pressure measurement from the referral should be
recorded here.
Example: 120 mmHg = 120

777 Unable to obtain

Systolic blood pressure measurement was attempted, but results
were not obtained due to technical difficulties or errors.
See Appendix B for the procedure for documenting the reason
that the measurement could not be obtained.
This value will be flagged as an error.

888 Client refuseda

Participant refuses to have their systolic blood pressure
measurement taken.
This value will be flagged as an error.

999 No measurement
recordeda

Systolic blood pressure measurement was not performed or not
recorded.
This value will be flagged as an error.

ANALYSIS AND USE

To identify those at increased risk for cardiovascular conditions, including heart attack, heart
failure, stroke, and kidney disease
To identify participants who would benefit from lifestyle programs
To identify participants unaware that they have hypertension (high blood pressure) for referral to
medical management
To determine control and management of blood pressure
To identify participants who require further diagnostic evaluation
To identify hypertension (high blood pressure) risk of the WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
Programs can submit up to four systolic blood pressure measurements. The first measurement
(positions 1 through 3 of SBP) should correspond to the systolic blood pressure measurement
on the clinical assessment date. If more than one measurement is obtained on the clinical
assessment date, with a one-minute interval as recommended by the American Heart
Association, the average systolic blood pressure measurement should be recorded in positions
1 through 3.

WISEWOMAN MDE Manual
Edition 23.1

OTHER
INFORMATION
(CONT.)

Programs may re-measure participants’ systolic blood pressure prior to a subsequent follow-up
assessment or re-assessment. If a program re-measures a participant’s systolic blood pressure
during follow-up, up to three additional systolic blood pressure measurements can be recorded
in positions 4 through 6 (re-measurement #1), positions 7 through 9 (re-measurement #2), and
positions 10 through 12 (re-measurement #3). Programs are not required to submit blood
pressure re-measurements (positions 4 through 12); however, if blood pressure remeasurements are recorded, the date of re-measurement should be provided in 5d: Monitored.
Systolic blood pressure measurement at assessment (positions 1 through 3 of SBP) is required
for a record to count as a complete or BP+ record. If positions 1 through 3 of SBP are blank or
coded as ‘777 Unable to obtain,’ ‘888 Participant refused,’ or ‘999 No measurement recorded,’
or is outside of the valid range (74-260 mmHg) the record will not count as a complete or BP+
record, and the record will not count toward meeting a program’s assessment goal. If
exceptional circumstances do not allow a blood pressure measurement during the clinical
assessment (cases where positions 1 through 3 of SBP are coded as ‘777 Unable to obtain’),
these reasons should be documented as instructed in Appendix B.

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 12c: DBP*

Diastolic Blood Pressure
This variable indicates the participant’s diastolic blood pressure readings.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

158

Leading Zeros:

Yes

Valid Range:

Static Field:

002-156; cannot be blank if TYPE
is 1, 2, 3 or 4 (baseline
assessment, re-assessment, or
follow-up assessment)

SOURCE

Not applicable; health assessment measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION
(CODE FOR EACH
READING AND IN
THE ORDER TAKEN)

Diastolic blood pressure
in mmHg

A three-digit (numeric) value representing the participant’s
diastolic blood pressure in mmHg
Diastolic blood pressure values between 2-12 mmHg or 122-156
mmHg will be flagged for quality checks and program verification.
Values outside 2-156 mmHg will be considered errors. See
Appendix B for the procedure for validating out-of-range values.
If a blood pressure measurement was not obtained at the time of
the office visit and obtained at a referral visit within 30 days of the
visit, the blood pressure measurement from the referral should be
recorded here.
Example: 85 mmHg = 085

777 Unable to obtain

Diastolic blood pressure measurement was attempted, but results
were not obtained due to technical difficulties or errors.
See Appendix B for the procedure for documenting the reason that
the measurement could not be obtained.
This value will be flagged as an error.

888 Client refuseda

Participant refuses to have their diastolic blood pressure
measurement taken.
This value will be flagged as an error.

999 No measurement
recordeda

Diastolic blood pressure measurement was not performed or not
recorded.
This value will be flagged as an error.

ANALYSIS AND USE

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
Programs can submit up to four diastolic blood pressure measurements. The first measurement
(positions 1 through 3 of DBP) should correspond to the diastolic blood pressure measurement
on the clinical assessment date. If more than one measurement is obtained on the clinical
assessment date, with a one-minute interval as recommended by the American Heart
Association, the average diastolic blood pressure measurement should be recorded in positions
1 through 3.

WISEWOMAN MDE Manual
Edition 23.1

OTHER
INFORMATION
(CONT.)

Programs may re-measure a participant’s diastolic blood pressure prior to a subsequent followup assessment or re-assessment. If a program re-measures a participant’s diastolic blood
pressure during follow-up, up to three additional diastolic blood pressure measurements can be
recorded in positions 4 through 6 (re-measurement #1), positions 7 through 9 (re-measurement
#2), and positions 10 through 12 (remeasurement #3). Programs are not required to submit
blood pressure re-measurements (positions 4 through 12); however, if blood pressure remeasurements are recorded, the date of re-measurement should be provided in 5d: Monitored.
Diastolic blood pressure measurement at assessment (positions 1 through 3 of DBP) is required
for a record to count as a complete or BP+ record. If positions 1 through 3 of DBP is blank or
coded as ‘777 Unable to obtain,’ ‘888 Client refused,’ or ‘999 No measurement recorded,’ or is
outside of the valid range (2-156 mmHg) the record will not count as a complete or BP+ record,
and the record will not count toward meeting a program’s assessment goal. If exceptional
circumstances do not allow a blood pressure measurement (cases where first blood pressure
measurement is coded as ‘777 Unable to obtain’), these reasons should be documented as
instructed in Appendix B.

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 13a: Fast*

Fasting Status
This variable indicates whether a participant fasted for at least nine hours prior to having
blood drawn for cholesterol or glucose measurements.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

170

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be blank if
TYPE is 1 or 2 (baseline
assessment or reassessment); cannot be blank
if Type = 3 or 4 when any of
the following are not blank:
Totchol, HDL, LDL, Trigly,
glucose

SOURCE

Not applicable; health assessment measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Yes

Participant fasted for at least nine hours prior to having blood
drawn.

2 No

Participant did not fast for at least nine hours prior to having
blood drawn.

9 No answer
recordeda

No answer recorded.
Provider failed to confirm fasting status, or no information is
available from the provider.
This value should be marked if 14a: TotChol, 14b: HDL, 14c:
LDL, 14d: Trigly, and 15a: Glucose all are equal to 999/9999,
777/7777, or 888/8888.
This value will be flagged as an error for baseline assessments,
and re-assessments, and for follow-up assessments where lab
work was conducted.

ANALYSIS AND USE

To facilitate accurate identification of participants who have high cholesterol, borderline high
cholesterol, diabetes, or pre-diabetes

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection
forms completed by the provider. They are provided for funded program use only.
If a participant reports that they do not know or refuses blood work, programs should have a
discussion with the participant to verify the response.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 14a: TotChol*

Total Cholesterol (nonfasting or fasting)
This variable indicates the participant’s total cholesterol level.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

171

Leading Zeros:

Yes

Valid Range:

Static Field:

044-702; cannot be blank if
TYPE is 1 or 2 (baseline
assessment or re-assessment)

SOURCE

Not applicable; health assessment measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Total cholesterol in
mg/dL

A three-digit (numeric) value representing the participant’s total
cholesterol in mg/dL
Total cholesterol values that are between 44 and 60 mg/dL or 400
and 702 mg/dL will be flagged for quality checks and program
verification. Values outside 44-702 will be considered errors. See
Appendix B for the procedure for validating out-of-range values.
Example: 130 mg/dL = 130

777 Inadequate blood
sample

Total cholesterol measurement was attempted, but results were not
obtained due to technical difficulties or errors.
This may include issues such as (1) two or more failed venipuncture
attempts; (2) insufficient amount of blood, type of test tube; (3)
invalid Cholestech readings due to very high/low values; (4) sample
submitted to laboratory, test not done due to erroneous or missing
laboratory request or other paperwork.
See Appendix B for the procedure for documenting the reason that
the measurement was not obtained.
This value will be flagged as an error.

888 Client refuseda

Participant refuses to have their blood drawn for cholesterol
measurements.
If the participant refuses to go to the lab, the participant can be
considered to have refused.
If the participant does not go to the scheduled lab appointment after
follow-up has been attempted, the participant can be considered to
have refused.
This value will be flagged as an error.

999 No measurement
recordeda

No total cholesterol measurement was taken or recorded.
This value will be flagged as an error for baseline assessments and
reassessments.

ANALYSIS AND USE

To identify participants who are unaware that they have high or borderline high cholesterol and
need preventive services or referral to medical management
To determine cholesterol control and management
To assess the percentage of WISEWOMAN participants who have high cholesterol or
borderline high cholesterol
To assess the risk in the WISEWOMAN population for cardiovascular disease
To provide data element required to determine participant’s cardiovascular risk score

WISEWOMAN MDE Manual
Edition 23.1

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
Total cholesterol measurement may be taken as nonfasting or fasting. At a minimum, every
participant must have a total cholesterol, HDL cholesterol (14b: HDL), and LDL cholesterol (14c:
LDL) value recorded.
Total cholesterol measurement at baseline assessment or reassessment is required for a record
to count as a complete or BP+ record. If TotChol is blank or coded as ‘777 Unable to obtain,’
‘888 Client refused, or ‘999 No measurement recorded,’ or is outside of the valid range (044702 mg/dL) the record will not count as a complete or BP+ record. If exceptional circumstances
do not allow TotChol measurement, these reasons should be documented in the Validation of
Data form as instructed in Appendix B.
Total cholesterol measurement may not be medically necessary at follow-up assessment if a
participant had normal cholesterol levels at baseline assessment anchored in American Heart
Association guidelines.

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 14b: HDL*

HDL Cholesterol (nonfasting or fasting)
This variable indicates the participant’s HDL cholesterol level.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

174

Leading Zeros:

Yes

Valid Range:

Static Field:

007-196; cannot be blank if
TYPE is 1 or 2 (baseline
assessment or reassessment)

SOURCE

Not applicable; health assessment measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

HDL cholesterol in
mg/dL

A three-digit (numeric) value representing the participant’s HDL
cholesterol in mg/dL
HDL cholesterol values that are between 155 and 196 mg/dL will be
flagged for quality checks and program verification. Values outside
007-196 mg/dL will be considered errors. See Appendix B for the
procedure for validating out-of-range values.
Example: 90 mg/dL = 090

777 Inadequate blood
sample

HDL cholesterol measurement was attempted, but results were not
obtained due to technical difficulties or errors.
This may include issues such as (1) two or more failed venipuncture
attempts; (2) insufficient amount of blood, type of test tube; (3)
invalid Cholestech readings due to very high/low values;(4) sample
submitted to laboratory, test not done due to erroneous or missing
laboratory request or other paperwork.
See Appendix B for the procedure for documenting the reason that
the measurement was not obtained.
This value will be flagged as an error.

888 Client refuseda

999 No measurement
recordeda

No HDL cholesterol measurement was taken or recorded.
This value will be flagged as an error for baseline assessments and
reassessments.

ANALYSIS AND USE

To identify participants who are unaware that they have low HDL cholesterol and need
preventive services or referral to medical management
To assess the percentage of WISEWOMAN participants who have high cholesterol or
borderline high cholesterol
To assess the risk of the WISEWOMAN population for cardiovascular disease
To assist in determining cholesterol control and management

WISEWOMAN MDE Manual
Edition 23.1

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
HDL cholesterol measurement may be taken as nonfasting or fasting. At a minimum, every
participant must have a total cholesterol, HDL cholesterol (14b: HDL), and LDL cholesterol (14c:
LDL) value recorded.
In cases where the Cholestech machine indicates a reading of less than 15 mg/dL, the
guidance is to code the participant’s HDL as 015.
HDL cholesterol measurement at baseline assessment or re-assessment is required for a
record to count as a complete or BP+ record. If HDL is blank or coded as ‘777 Unable to obtain,’
‘888 Client refused’, or ‘999 No measurement recorded,’ or is outside of the valid range (007196 mg/dL) the record will not count as a complete or BP+ record. If exceptional circumstances
do not allow HDL measurement, these reasons should be documented in the Validation of Data
form as instructed in Appendix B.
HDL cholesterol measurement may not be medically necessary at follow-up assessment if a
participant had normal cholesterol levels at baseline assessment anchored in American Heart
Association guidelines.

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 14c: LDL*

LDL Cholesterol (nonfasting or fasting)
This variable indicates a participant’s LDL cholesterol level

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

177

Leading Zeros:

Yes

Valid Range:

Static Field:

020-380: cannot be blank if
TYPE is 1 or 2 (baseline
assessment or reassessment)

SOURCE

2018 AHA/ACC Guideline on the Management of Blood Cholesterol

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

LDL cholesterol in
mg/dL

A three-digit (numeric) value representing a participant’s LDL
cholesterol in mg/dL
LDL cholesterol values that are between 344 and 380 mg/dL will be
flagged for quality checks and program verification. LDL cholesterol
values that are outside 020 and 380 mg/dL will be considered errors.
See Appendix B for the procedure for validating out-of-range values.
For nonfasting participants who are on lipid-lowering therapy, have a
history of high cholesterol, or have a triglyceride level >0400 mg/dL,
any value in this field will be flagged for an error. See below for
additional guidance.
Example: 90 mg/dL = 090

777 Inadequate blood
sample

LDL cholesterol measurement was attempted, but results were not
obtained due to technical difficulties or errors.
This may include issues such as (1) two or more failed venipuncture
attempts; (2) insufficient amount of blood, type of test tube; (3)
invalid Cholestech readings due to very high/low values; (4) sample
submitted to laboratory, test not done due to erroneous or missing
laboratory request or other paperwork.
This response should also be used for participants on lipid-lowering
therapy with a history of high cholesterol who were confirmed to be
fasting, but their LDL cholesterol was unable to be obtained.
This value will be flagged as an error.

888 Client refuseda

Participant refuses to receive a lipid panel that would include LDL
measurements.
This response should also be used for participants on lipid-lowering
therapy or with a history of high cholesterol who were confirmed to
be fasting but refused a lipid panel.
This value will be flagged as an error.

999 No measurement
recordeda

No LDL cholesterol measurement was taken or recorded
Nonfasting participants who are on lipid-lowering therapy, have a
history of high cholesterol, or have a triglyceride level >0400 mg/dL
should always have this value.

ANALYSIS AND USE

To assist in determining cholesterol control and management

WISEWOMAN MDE Manual
Edition 23.1

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.

At a minimum, every participant must have a total cholesterol, HDL cholesterol (14b: HDL) and
LDL cholesterol (14C: LDL) value recorded.
LDL cholesterol measurement at baseline assessment or re-assessment is required for a record
to count as a complete or BP+ record. If LDL is blank or coded as ‘777 Unable to obtain,’ ‘888
Client refused, or ‘999 No measurement recorded,’ or is outside of the valid range (020-380
mg/dL) the record will not count as a complete or BP+ record. If exceptional circumstances do
not allow LDL measurement, these reasons should be documented in the Validation of Data
form as instructed in Appendix B.
g.
LDL cholesterol measurement may not be medically necessary at follow-up assessment if a
participant had normal cholesterol levels at baseline assessment based on American Heart
Association guidelines.
As per the 2018 AHA/ACC Guideline on the Management of Blood Cholesterol, measurement
of either a fasting or a nonfasting plasma lipid profile is effective in estimating initial ASCVD risk
if the participant is not on lipid-lowering therapy and does not have a history of high cholesterol.
Therefore, although assessing lipids when the participant is fasting may be more prudent, for
participants not on lipid-lowering therapy and without a history of high cholesterol, LDL
cholesterol may be measured for fasting or nonfasting participants. It is not recommended to
measure nonfasting LDL if a participant has consumed an extremely high-fat meal 8 hours prior
to blood work. In this case, blood work should be measured on another day (preferably fasting).
Additionally, for any participants with a family history of heart attacks or other atherosclerotic
disease at an early age (< 50-55 years) or who have a genetic history of hyperlipidemia, it is
reasonable to obtain an initial fasting lipid profile.
For participants on lipid-lowering therapy, or who have a history of high cholesterol, LDL
cholesterol should be measured only when the participant is fasting. If a participant meets either
of these criteria and is not fasting when cholesterol is initially measured, the provider may remeasure fasting cholesterol within 30 days of the office visit. In this case, the fasting status
(13a: Fast), total cholesterol (14a:TotChol), HDL cholesterol (14b:HDL), LDL cholesterol (14c:
LDL), and triglycerides (14d:trigly) values should also be updated in the assessment record.
For participants who are not on lipid-lowering therapy and do not have a history of high
cholesterol, but who were not fasting and had a triglyceride (14d: Trigly) level greater than or
equal to 400 mg/dL, blood work should be performed again as a fasting measurement within 30
days of the initial assessment. In this case, the fasting status (13a: Fast), total cholesterol
(14a:TotChol), HDL cholesterol (14b:HDL), LDL cholesterol (14c: LDL), and triglycerides
(14d:Trigly) values should also be updated in the assessment record.
If an LDL measurement is recorded when the participant was not confirmed to be fasting,
programs should check with providers to determine whether the participant was fasting.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 14d: Trigly

Triglycerides (fasting or nonfasting)
This variable indicates a participant’s triglycerides measurement.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

180

Leading Zeros:

Yes

Valid Range:

0012-3000

Static Field:

SOURCE

2018 AHA/ACC Guideline on the Management of Blood Cholesterol

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Triglycerides in mg/dL

A four-digit (numeric) value representing a participant’s triglycerides
measurement in mg/dL
For fasting participants, triglycerides values between 1,000 and
3,000 mg/dL will be flagged for quality checks and program
verification. Values outside 0012-3000 mg/dL will be considered
errors. See Appendix B for the procedure for validating out-of-range
values.
For nonfasting participants who are on lipid-lowering therapy or have
a history of high cholesterol, any value in this field will be flagged for
an error.
For nonfasting participants who are NOT on a lipid-lowering therapy
and do NOT have a history of high cholesterol, a triglycerides level
outside 0012-0400 mg/dL will be flagged for an error. In this case,
programs should repeat the lipid panel within 30 days to obtain the
fasting values. See additional guidance below.
Example: 90 mg/dL = 0090

ANALYSIS AND USE

7777 Inadequate
blood sample

Triglycerides measurement was attempted, but results were not
obtained due to technical difficulties or errors.
This may include issues such as (1) two or more failed venipuncture
attempts; (2) insufficient amount of blood, type of test tube; (3)
invalid Cholestech readings due to very high/low values; (4) sample
submitted to laboratory, test not done due to erroneous or missing
laboratory request or other paperwork.
This response should also be used for participants on lipid-lowering
therapy or with a history of high cholesterol who were confirmed to
be fasting, but their triglycerides measurement could not be
obtained.

8888 Client refuseda

Fasting participant refuses to receive a lipid panel that would include
triglycerides measurements.
This response should also be used for participants on lipid-lowering
therapy or with a history of high cholesterol who were confirmed to
be fasting but refused a lipid panel.

9999 No measurement
recordeda

No triglycerides measurement was taken or recorded.
Nonfasting participants who are on lipid-lowering therapy or have a
history of high cholesterol should always have this value.

To assist in determining cholesterol control and management

WISEWOMAN MDE Manual
Edition 23.1

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.

At a minimum, every participant must have a total cholesterol, HDL cholesterol (14b: HDL) and
LDL cholesterol (14C: LDL). A triglyceride (14d: Trigly) value can also be recorded in addition to
total cholesterol, HDL cholesterol, and LDL cholesterol. Triglycerides measurement may not be
medically necessary at follow-up assessment if a participant had normal cholesterol levels at
baseline assessment based on American Heart Association guidelines.
As per the 2018 AHA/ACC Guideline on the Management of Blood Cholesterol, measurement
of either a fasting or a nonfasting plasma lipid profile is effective in estimating initial ASCVD risk
if the participant is not on lipid-lowering therapy and does not have a history of high cholesterol.
Therefore, although assessing lipids when the participant is fasting may be more prudent, for
participants not on lipid-lowering therapy and without a history of high cholesterol, triglycerides
may be measured for fasting or nonfasting participants. It is not recommended to measure
nonfasting triglycerides if a participant has consumed an extremely high-fat meal 8 hours prior
to blood work. In this case, blood work should be measured on another day (preferably fasting).
Additionally, for any participants with a family history of heart attacks or other atherosclerotic
disease at an early age (< 50-55 years) or who have a genetic history of hyperlipidemia, it is
reasonable to obtain an initial fasting lipid profile.
For participants on lipid-lowering therapy or with a history of high cholesterol, triglycerides
should be measured only when the participant is fasting. If a participant is not fasting when
cholesterol is initially measured, the provider may re-measure fasting cholesterol within 30 days
of the office visit. In this case, the fasting status (13a: Fast), total cholesterol (14a:TotChol),
HDL cholesterol (14b: HDL), LDL cholesterol (14c: LDL), and triglycerides (14d: Trigly) values
should also be updated in the assessment record.
For participants who are not on lipid-lowering therapy and do not have a history of high
cholesterol, but who were not fasting and had a triglyceride level greater than or equal to 400
mg/dL, blood work should be performed again as a fasting measurement within 30 days of the
initial assessment. If a provider decides to re-measure the cholesterol within 30 days of the
office visit so that the values are fasting, the fasting status (13a:Fast), total cholesterol
(14a:TotChol), HDL cholesterol (14b:HDL), LDL cholesterol (14c: LDL), and triglycerides
(14d:Trigly) values should also be updated in the assessment record.
If a triglyceride measurement is recorded when the participant was not confirmed to be fasting,
programs should check with providers to determine whether the participant actually was fasting.

WISEWOMAN MDE Manual
Edition 23.1

Item 15a: Glucose*

Glucose (fasting)
This variable indicates the participant’s fasting glucose measurement.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

184

Leading Zeros:

Yes

Valid Range:

Static Field:

037-571; cannot be blank if A1C is
invalid and TYPE is 1 or 2
(baseline assessment or reassessment)

SOURCE

American Heart Association

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Total glucose in
mg/dL

Up to a three-digit (numeric) value representing the participant’s
fasting glucose level in mg/dL
Glucose values that are between 037 and 050 mg/dL or 275 and 571
mg/dL will be flagged for quality checks and program verification.
Values outside 037-571 will be considered errors. See Appendix B
for the procedure for validating out-of-range values.
Example: 90 mg/dL = 090

777 Inadequate blood
sample

Glucose measurement was attempted, but results were not obtained
due to technical difficulties or errors.
See Appendix B for the procedure for documenting the reason that
the measurement was not obtained.
This may include issues such as (1) two or more failed venipuncture
attempts; (2) insufficient amount of blood, type of test tube; (3)
invalid Cholestech readings due to very high/low values; (4) sample
submitted to laboratory, test not done due to erroneous or missing
laboratory request or other paperwork.
This value will be flagged as an error if A1C is also invalid.

888 Client refuseda

Participant refuses to have their blood drawn for glucose
measurements.
If the participant refuses to go to the lab, the participant can be
considered to have refused.
If the participant does not go to the scheduled lab appointment after
follow-up has been attempted, the participant can be considered to
have refused.
This value will be flagged as an error if A1C is also invalid.

999 No measurement
recordeda

No glucose measurement was taken for record.
Non-fasting participants should always have this value.
This value will be flagged as an error if A1C is also invalid.

ANALYSIS AND USE

To identify participants who have pre-diabetes and diabetes
To assist in determining diabetes control and management
To use blood glucose or A1C percentage to accurately assess a participant’s diabetes status
To provide data element required to determine participant’s cardiovascular risk
To understand the overall rate of diabetes among the WISEWOMAN population

WISEWOMAN MDE Manual
Edition 23.1

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection form
completed by the provider. They are provided for funded program use only.
Glucose must be a fasting measurement. Programs may record both a glucose and A1C
measurement for a participant. Having values for both Glucose and A1C will not result in an
error.
In cases where the Cholestech machine indicates a reading of less than 37 mg/dL, the
guidance is to code the participant’s glucose as 037. Such a reading can identify an imminent
danger and requires urgent care.

A valid glucose measurement or A1C measurement at assessment is required for a record to
count as a complete record.
Values are considered invalid for the glucose variable if: (1) participant is fasting and glucose is
left blank or coded as ‘777 Unable to obtain,’ ‘888 Client refused, or ‘999 No measurement
recorded, or is outside of the valid range (037-571 mg/dl), or (2) participant is not fasting.
Values are considered invalid for A1C variable if: (1) it is left blank, coded as ‘7777 Unable to
obtain,’ ‘8888 Client refused, or ‘9999 No measurement recorded,’ or is outside of the valid
range (02.8-16.2 mg/dL).
If exceptional circumstances do not allow Glucose measurement, these reasons should be
documented in the Validation of Data form as instructed in Appendix B.
*Complete require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 15b: A1C*

A1C Percentage
This variable indicates the participant’s A1C percentage (if measured).

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:
Leading Zeros:

4
Yes

Beginning Position:
Valid Range:

Static Field:

187
02.8-16.2; cannot be blank if
Glucose is blank and TYPE is 1 or 2
(baseline assessment or reassessment)

SOURCE

Not applicable; health assessment measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

A1C percentage

Numeric value representing the participant’s A1C percentage. A1C
should be reported to one decimal point
If A1C was measured by another provider within the last 3 months,
it is acceptable to input the value if it is available.
A1C values between 02.8% and 04.0% or 13.0% and 16.2% will be
flagged for quality checks and program verification. Values outside
02.8%-16.2% will be considered errors. See Appendix B for the
procedure for validating out-of-range values.
Example: 8.5% = 08.5 (where the decimal place counts as part of
the variable length)

7777 Inadequate blood
sample

A1C measurement was attempted, but results were not obtained
due to technical difficulties or errors.
This value will be flagged as an error if glucose is also invalid.

8888 Client refuseda

Participant refuses to have an A1C test.
If a participant refuses to go to the lab, the participant can be
considered to have refused.
If a participant does not go to the scheduled lab appointment after
follow-up has been attempted, the participant can be considered to
have refused.
This value will be flagged as an error if glucose is also invalid.

9999 No measurement
recordeda

No A1C measurement was taken or recorded.
This value will be flagged as an error if glucose is also invalid.

ANALYSIS AND USE

OTHER
INFORMATION

To identify participants who have diabetes and refer them for medical management
To identify participants who have higher-than-optimal A1C levels and would benefit from
preventive services such as lifestyle programs
To assist in determining diabetes control and management
To assess the cardiovascular disease risk factors in the WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score
aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
Participants with A1C percentage values greater than or equal to 6.5% are considered diabetic.
Participants with A1C percentage values less than 6.5% but greater than or equal to 5.7% are
considered pre-diabetic.
Programs may record both a glucose and A1C measurement for a participant. Having values for
both Glucose and A1C will not result in an error.
A1C measurement or glucose measurement at assessment is required for a record to be a
complete record. If both Glucose and A1C are blank or coded as ‘777 Unable to obtain,’ ‘888
Client refused, or ‘999 No measurement recorded, or are outside of the valid range (Glucose:
37-571 mg/dL; A1C: 2.8-16.2%), the record will not count as a complete record. If exceptional
circumstances do not allow A1C measurement, these reasons should be documented in the
Validation of Data form as instructed in Appendix B.
Note that WISEWOMAN does not designate an alert value for A1C, because the A1C value
itself is a three-month average and is not accurate enough to identify that an individual’s life is in
imminent danger and requires urgent care.
A1C percentage values are not affected by fasting status.

WISEWOMAN MDE Manual
Edition 23.1

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 16a: BPAlert

Is a medical follow-up for blood pressure reading necessary?
This variable indicates whether medical follow-up for a participant’s alert level blood pressure is
medically necessary, as indicated by a SBP greater than 180 mmHg or DBP greater than 120
mmHg.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

191

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be blank if
TYPE is 1, 2, 3 or 4 (baseline
assessment, re-assessment, or
follow-up assessment)

SOURCE

JNC7 and American Heart Association 2017 guidelines

DENOMINATOR
POPULATION

Participants who have an alert level blood pressure value are included in the denominator.

VALUES AND
DESCRIPTION

Medically necessary

Medical follow-up for blood pressure is medically
necessary.

Not medically needed

Medical follow-up for blood pressure is not medically
necessary.

Medically necessary followup appointment declined

Medical follow-up for blood pressure is medically necessary
but participant failed to attend follow-up appointment.

Client refused workupa

Participant had an alert level blood pressure reading but
refused workup.

No answer recordeda

No answer recorded. This value will be flagged as an error.

ANALYSIS AND USE

To assess whether participants with alert level blood pressure readings are receiving a workup
To assist in determining hypertension (high blood pressure) management, and control

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
A participant is classified as having an alert blood pressure reading if their systolic blood
pressure reading measured during the assessment (12b: SBP, positions 1 – 3) is greater than
180 mmHg or if their diastolic blood pressure reading at assessment (12c: DBP, positions 1 –
3)) is greater than 120 mmHg.
“3 Medically necessary follow-up appointment declined” should be used when a client had an
alert value and was scheduled to follow-up with a medical provider in within 7 days, however,
the client did not show-up for the appointment.
“8 Client refused workup” should be used when the client had an alert value, however, they
refused to schedule a follow-up with a medical provider.

WISEWOMAN MDE Manual
Edition 23.1

Item 16b: BPDiDate

What is the date of the medically necessary follow-up appointment?
This variable indicates the follow-up appointment date for a participant with an alert level blood
pressure reading.

FORMAT

Type:

Numeric

Other Format:

MMDDCCYY

Item Length:

Justification:

Right

Field Length:

Beginning Position:

192

Leading Zeros:

Yes

Valid Range:

Static Field:

Valid date; cannot be blank if TYPE
is 1, 2, 3 or 4 (baseline assessment,
re-assessment, or follow-up
assessment)

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

Participants who have an alert level blood pressure value are included in the denominator.

VALUES AND
DESCRIPTION

Medically Necessary
Follow-up
Appointment Date

ANALYSIS AND USE

To assess whether providers are performing timely workups for participants with alert level
blood pressure values
To determine whether programs are meeting the guideline of workups within one week of the
assessment for alert participants
To assist in determining hypertension (high blood pressure) prevention, management, and
control

OTHER
INFORMATION

A participant is classified as having an alert blood pressure reading if their systolic blood
pressure reading measured at the assessment visit (12b: SBP, positions 1 - 3) is greater than
180 mmHg or if their diastolic blood pressure reading measured at the assessment visit (12c:
DBP, positions 1 - 3) is greater than 120 mmHg.
Only participants who are coded as having an alert blood pressure reading (16a: BPAlert = ‘1
Medically necessary,’ 3 Medically necessary – follow-up appointment declined,‘ 8 Client refused
workup,’ or ‘9 Workup not completed’) should have a blood pressure diagnostic exam date.
However, in cases where blood pressure readings are just under the alert threshold (SBPs >
165 and ≤ 180 and DBPs >110 and ≤ 120) a valid BPDiDate will result in a quality check rather
than an error. If a participant with an alert blood pressure value has a blood pressure workup
status (16a: BPAlert) coded as ‘‘1 Medically necessary,’ this field must be completed with the
date of the diagnostic exam.
If a participant with an alert blood pressure value has a blood pressure workup status (16a:
BPAlert) coded as ‘3- Medically necessary- follow-up appointment declined’ or ‘8 Client refused
workup,’ this field should contain the date of refusal as defined by program protocol.
If a participant with an alert blood pressure value has a blood pressure workup status (16a:
BPAlert) coded as ‘9 Workup not completed,’ this field should contain the date that the program
considered the participant lost to follow-up as defined by program protocol

WISEWOMAN MDE Manual
Edition 23.1

Valid date in MMDDCCYY format
If follow-up information is provided for this referral, the workup date
can be entered.
Example: December 01, 2023 = 12012023

7. RISK REDUCTION COUNSELING MDE SPECIFICATIONS
This section provides recipients with the information necessary to support collection and
reporting of the Risk Reduction Counseling MDE, which must be done according to the
specifications provided in this section of the manual. Risk reduction counseling should be
provided at all assessments.4
For a record to be counted as a Complete assessment, it must have valid values for required
MDEs. Definitions of Complete assessments are provided in Appendix A.
This section begins with a summary of the required variable (Subsection a) and then provides
the technical specifications for the variable (Subsection b).

Values left blank are considered invalid values for risk reduction counseling completion date.

WISEWOMAN MDE Manual
Edition 23.1

a. Summary of Risk Reduction Counseling MDEs
Item
Number
17a

Variable Name
RRCComplete

WISEWOMAN MDE Manual
Edition 23.1

Beginning
Position

Variable Label

200

Risk reduction counseling completion date

Type
Numeric

b. Risk Reduction Counseling MDE Specifications
Item 17a:
RRCComplete*

Risk Reduction Counseling Completion Date
This variable indicates the date that risk reduction counseling was completed.

FORMAT

Type:

Numeric

Other Format:

MMDDCCYY

Item Length:

Justification:

Right

Field Length:

Beginning Position:

200

Leading Zeros:

Yes

Valid Range:

Static Field:

Valid date; cannot be blank if TYPE
is 1, 2, 3 or 4 (baseline
assessment, re-assessment, or
follow-up assessment)

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Risk reduction counseling
follow-up date

Valid date in MMDDCCYY format
Date must occur within the submission period.
Example: December 01, 2023 = 12012023

88888888 Participant refused
further program contacta

Participant refused further program contact.
This value will be flagged as a quality check.

99999999 Participant lost to
follow-upa

Provider made three attempts to follow-up with participant, but
participant lost to follow-up.
This value will be flagged as a quality check.

ANALYSIS AND USE

To determine the date of a completed risk reduction counseling session, which should be
provided for all assessments
To facilitate analysis of changes in risk reduction counseling provision over time

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
If risk reduction counseling is completed on the same date as the clinical assessment, the same
date should be recorded for 12a: BPDate and 17a: RRCComplete.
If laboratory results are not available at the time of the assessment visit to provide risk reduction
counseling, this field should be used to indicate the date on which risk reduction counseling was
completed.
If RRCComplete is blank the record will not count as a complete record.
*Complete records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

8. HEALTHY BEHAVIOR SUPPORT SERVICES MDE SPECIFICATIONS
This section provides recipients with the information necessary to support collection and
reporting of Lifestyle Program/Health Coaching MDEs as well as referrals to communitybased tobacco cessation resources which must be done according to the specifications
provided in this section of the manual.
For a record to be counted as a Complete or BP+ assessment, it must have valid values for
required MDEs. Definitions of complete and BP+ assessments are provided in
Appendix A.
An LSP/HC contact is counted if the following MDE variables in a record have valid values:
date of LSP/HC session, LSP/HC ID, and date of referral.5 Recipients may report LSP/HC
data that do not meet these requirements, but they will not be counted as an LSP/HC
session, analyzed in data reports generated by CDC, or counted in the related performance
measure unless additional documentation is provided.
This section begins with a summary of the seven required variables (Subsection a) and then
provides the technical specifications for each variable (Subsection b).

5 If a valid date of an LSP/HC session is provided, values left blank for LSPHCID or that are not included on the current list
of CDC-approved LSP/HC IDs, are considered invalid values. If the date of an LSP/HC session is blank, then the LSP/HC
contact will not be counted.

WISEWOMAN MDE Manual
Edition 23.1

a. Summary of Healthy Behavior Support Services MDEs
Item
Number

Variable
Name

Beginning
Position

Variable Label

Type

18a

RefDate

208

Lifestyle Program (LSP) / Health Coaching (HC)
referral date

Numeric

19a

LSPHCRec

224

Number of Lifestyle Program (LSP) / Health
Coaching (HC) Sessions Received by the
Participant Associated with the Current Screening
(Assessment)

Numeric

19b

Intervention

226

Date of Lifestyle Program (LSP) / Health Coaching
(HC) session)

Numeric

19c

LSPHCID

354

Lifestyle Program (LSP) / Health Coaching (HC) ID

Character

20a

TobResDate

514

Date of referral to Tobacco Cessation Resource

Numeric

20b

TobResType

538

Type of Tobacco Cessation Resource

Numeric

20c

TResComp

541

Tobacco Cessation activity completed

Numeric

WISEWOMAN MDE Manual
Edition 23.1

b. Healthy Behavior Support Services MDE Specifications
Item 18a: RefDate*

Lifestyle Program (LSP) / Health Coaching (HC) Referral Date
This variable indicates the date that a referral to an LSP/HC occurred.

FORMAT

Type:

Numeric

Other Format:

MMDDCCYY

Item Length:

Justification:

Right

Field Length:

Beginning Position:

208

Leading Zeros:

Yes

Valid Range:

Valid date

Static Field:

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Lifestyle Program/Health
Coaching Referral Date

Valid date in MMDDCCYY format
Date must occur within the submission period.
Example: December 01, 2023 = 12012023

8888888888888888
refused to answer

Participant refused LSP/HC referral.
This value will be flagged as a quality check.

ANALYSIS AND USE

To determine the date of the referral to an LSP/HC
To assist in determining whether the participant has received a referral to an LSP/HC
To assist in determining the number of LSP/HC referrals per participant
To facilitate analysis of changes in LSP/HC referrals over time

OTHER
INFORMATION

To calculate the number of LSP or HC referrals per participant, the number of LSP/HC referral
dates is counted for each unique participant ID (3a: EncodeID).
For each assessment, up to two referral dates can be recorded in this field and the Refdate
should be recorded in the order in which the referrals occurred.
If a provider attempts to refer a participant to an LSP/HC but the participant refuses to be
referred, a value of 8888888888888888 should be entered.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 19a: LSPHCRec*

Number of Lifestyle Program (LSP) / Health Coaching (HC) Sessions Received by the
Participant Associated with the Current Screening (Assessment)
This variable indicates the number of LSP/HC sessions the participant has received during the
current assessment prior to a subsequent follow-up assessment or re-assessment.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

224

Leading Zeros:

Yes

Valid Range:

Static Field:

Cannot be blank if
Refdate is valid

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Number of Sessions

ANALYSIS AND USE

To track the number of LSP/HC sessions that the participant has received

Value representing the number of LSP/HC sessions the participant
has received associated with the current assessment
Example: 6 visits = 06

OTHER
INFORMATION

The number of LSP and HC sessions the participant has received during the current
assessment (prior to a subsequent follow-up assessment or re-assessment) should be provided
in this field. During the creation of the analytic file, CDC will check that the number of LSP/HC
sessions received by the participant is equal to the number of unique LSP/HC dates provided
during the cooperative agreement period. Sessions will not count unless the record also
contains a valid LSP/HC referral date (18a: RefDate).
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 19b: Intervention

Date of Lifestyle Program (LSP) / Health Coaching (HC) Session
For LSP/HC records, this variable indicates the date that the LSP/HC session occurred.

FORMAT

Type:

Numeric

Other Format:

MMDDCCYY

Item Length:

Justification:

Right

Field Length:

128

Beginning Position:

226

Leading Zeros:

Yes

Valid Range:

Valid date

Static Field:

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All LSP/HC sessions among WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Lifestyle Program/Health
Coaching Session Date

ANALYSIS AND USE

To determine the date of the LSP/HC session
To assist in determining whether the participant has received an LSP/HC session
To assist in calculating the number of LSP/HC sessions per participant
To assess whether participants with risk factors receive LSP/HC services
To assess changes in risk profile between participants who participate in the LSP/HC and
participants who do not

OTHER
INFORMATION

To calculate the number of LSP or HC sessions per participant, the number of LSP/HC session
dates is counted for each unique participant ID (3a: EncodeID).
Programs can enter up to 16 LSP/HC intervention dates per assessment. If additional sessions
are provided to a participant before a subsequent follow-up assessment or re-assessment,
these sessions should be recorded in the Supplemental LSP/HC Session form, as described in
Appendix B.
LSP/HC intervention dates should be recorded on the assessment record during which the
referral was made. For example, if a referral to health coaching was made during the baseline
assessment, the intervention dates should be recorded on this record, until a new referral is
made during a subsequent assessment.

WISEWOMAN MDE Manual
Edition 23.1

Valid date in MMDDCCYY format
Date must occur within the submission period.
Example: December 01, 2023 = 12012023

Item 19c: LSPHCID

Lifestyle Program (LSP) / Health Coaching (HC) ID
This variable indicates which LSP/HC was used.

FORMAT

Type:

Character

Other Format:

N/A

Item Length:

Justification:

Left

Field Length:

160

Beginning Position:

354

Leading Zeros:

N/A

Valid Range:

Static Field:

Valid code for an LSP/HC;
cannot be blank if valid date
provided for Intervention

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All LSP/HC sessions among WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Lifestyle Program ID
Health Coaching ID

ANALYSIS AND USE

To assess the number of WISEWOMAN participants who receive an LSP/HC session from each
WISEWOMAN LSP/HC provider
To describe differences in participant demographics or other characteristics by LSP/HC provider
To identify the number of LSP/HC providers in each geographic area

OTHER
INFORMATION

If the participant receives an LSP or HC session, the LSP/HC ID should be provided in this field.

WISEWOMAN MDE Manual
Edition 23.1

Value representing the ID code of the LSP as assigned
Value representing the ID code of the HC as assigned

Item 20a:
TobResDate

Date of Referral to Tobacco Cessation Resource
This variable indicates the date that the referral to a tobacco cessation resource occurred.

FORMAT

Type:

Numeric

Other Format:

MMDDCCYY

Item Length:

Justification:

Right

Field Length:

Beginning
Position:

514

Leading Zeros:

Valid Range:

Static Field:

Valid date; cannot be
blank if Smoker=1

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

WISEWOMAN participants with a Complete/BP+ baseline assessment who identify themselves
as current smokers.

VALUES AND
DESCRIPTION

Tobacco Cessation
Resource Referral Date

Valid date in MMDDCCYY format
Date must occur within the submission period.
Example: December 01, 2023 = 12012023

888888888888888888888888
refused to answer

Participant refused tobacco cessation resource referral.
This value will be flagged as a quality check if the participant
identifies as a current smoker.

ANALYSIS AND USE

To document the date of a referral to tobacco cessation resource
To assist in tracking receipt of tobacco cessation resource

OTHER
INFORMATION

To calculate the number of tobacco cessation resources referrals per participant, the number of
tobacco cessation resource referral dates is counted for each unique participant ID (3a:
EncodeID).
If a participant is referred to one or more tobacco cessation resources, the date of referral (Item
20a:TobResDate), type of resource the participant was referred to (Item 20b: TobResType), and
completion status for the resource at the end of the current assessment (Item 20c: TResComp)
should be recorded for each referral. The positions for the type of resource and completion
status of resource for each referral should align with the position of the date of referral. For
example, if a participant receives two referrals during the assessment period, the date of
referral, type of resource, and completion status for the second referral should be provided in
the second position for each item.
If a provider attempts to refer a participant to tobacco cessation resource but the participant
refuses to be referred, a value of 888888888888888888888888 should be entered.

WISEWOMAN MDE Manual
Edition 23.1

Item 20b: TobResType

Type of Tobacco Cessation Resource
This variable indicates the type of tobacco cessation resource that the participant was referred
to.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

538

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be
blank if valid date provided
for TobResDate

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

WISEWOMAN participants with a Complete/BP+ baseline assessment who identify
themselves as current smokers.

VALUES AND
DESCRIPTION

Quit line

Participant was referred to a proactive tobacco quit line.

Community-based
tobacco program

Participant was referred to a community-based tobacco
program.

Other tobacco cessation
resources

Participant was referred to other tobacco cessation
resources.

Internet-based tobacco
program

Participant was referred to an internet-based tobacco
program.

9 No answer recordeda

ANALYSIS AND USE

OTHER
INFORMATION

No answer was recorded.
This value will be flagged as an error if a valid date is
provided for TobResDate.

To determine the number of smokers that received a referral to tobacco cessation resource
To determine how frequently different types of tobacco cessation resources are being used
within and across programs
To compare the smoking status at follow-up and re-assessment of participants who were
linked to tobacco cessation resources versus those who were not
aCodes

and response options highlighted in gray should not appear on the data collection
forms completed by the provider. They are provided for funded program use only.

WISEWOMAN MDE Manual
Edition 23.1

Item 20c: TResComp

Tobacco Cessation Activity Completed
This variable indicates whether the participant completed tobacco cessation activity.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

541

Leading Zeros:

Valid Range:

Static Field:

See values; cannot be
blank if valid date
provided for TobResDate

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

WISEWOMAN participants with a Complete/BP+ baseline assessment who identify themselves
as current smokers.

VALUES AND
DESCRIPTION

Yes – Completed tobacco
cessation activity

Participant completed tobacco cessation activity.

No – Partially completed
tobacco cessation activity

Participant partially completed tobacco cessation activity.

No – Discontinued from
tobacco cessation activity
when reached

Participant decided to discontinue tobacco cessation
counseling when contacted by the tobacco cessation
resource.

No – Could not reach to
conduct tobacco cessation
activity

Participant could not be reached when contacted by the
tobacco cessation resource.

9 No answer recordeda

No answer was recorded.
This value will be flagged as an error if a valid date is
provided for TobResDate.

ANALYSIS AND USE

To determine the number of smokers that participated in tobacco cessation activities
To compare the smoking status at follow-up and re-assessment of participants who were linked
to tobacco cessation resources versus those who were not linked to tobacco cessation
resources

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
If a participant receives a referral to a tobacco cessation resource but the completion status of
the resource is unknown, TResComp should be coded as 2 (No – Partially completed tobacco
cessation activity) and updated accordingly if the completion status becomes available.

WISEWOMAN MDE Manual
Edition 23.1

9. SOCIAL DETERMININANTS OF HEALTH MDE SPECIFICATIONS
This section provides recipients with the information necessary to support collection and
reporting of Social Determinants of Health MDEs as well as referrals to specific social support
services offered by partners which must be done according to the specifications provided in
this section of the manual.
For a record to be counted as a Complete or BP+ assessment, it must have valid values for
required MDEs. Definitions of complete and BP+ assessments are provided in Appendix A.
This section begins with a summary of the 12 MDEs (Subsection a) and then provides the
technical specifications for each MDE (Subsection b).

WISEWOMAN MDE Man
Version 23.1

a. Summary of Social Determinants of Health MDEs
Item
Number

Variable
Name

Beginning
Position

Variable Label

Type

21a

CompUse

544

Do you use any of the following types of computer?
•
Desktop/Laptop
•
Smartphone
•
Tablet/Other portable wireless
Computer

Numeric

21b

IntAcc

545

Do you or any member of this household have
access to the internet?

Numeric

21c

FoodInsec

546

During the last 12 MONTHS, was there a time when
you were worried you would run out of food because
of a lack of money or other resources?

Numeric

21d

TranBarr

547

Have you ever missed a doctor’s appointment
because of transportation problems?

Numeric

21e

Childcare

548

Type of Childcare Services

Numeric

21f

ChildBarr

552

Have you had any of these child-care related
problems during the past year? (Select all that
apply)

Numeric

21g

Housing

558

What is your housing situation today?

Numeric

21h

IntPartViol

559

The following will ask about how safe you feel:
•
How often does your partner physically
hurt you?
•
How often does your partner insult or talk
down to you?

Numeric

21i

MedAdher

560

These four items are related to medication-taking
adherence:
•
Do you ever forget to take your (name of health
condition) medicine?
•
Are you careless at times about taking your
(name of health condition) medicine?
•
When you feel better, do you sometimes stop
taking your (name of health condition)
medicine?
•
Sometimes if you feel worse when you take
your (name of health condition) medicine, do
you stop taking it?

Numeric

22a

SocSerID

561

Social Service ID

Numeric

22b
22c

SocSerDate
SocSerUtil

671
759

Social Service Referral Date
Date of Social Services and Support Utilization

Numeric
Numeric

WISEWOMAN MDE Manual
Edition 23.1

b. Social Determinant of Health MDE Specifications
Item 21a: CompUse*

Do you use any of the following types of computers?
•
Desktop/Laptop
•
Smartphone
•
Tablet/Other portable wireless Computer
This variable indicates if the participant can access and use any personal desktop/laptop,
smartphone and/or tablet/Other portable wireless computer.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

544

Leading Zeros:

Valid Range:

See values

Static Field:

Yes

SOURCE

Adapted from American Community Survey

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Yes

Participant reports use of a personal desktop/laptop, smartphone
and/or tablet/Other portable wireless computer.

2 No

Participant does not report use of a personal desktop/laptop,
smartphone and/or tablet/Other portable wireless computer.

7 Don’t know

Participant does not know whether they use a personal
desktop/laptop, smartphone and/or tablet/Other portable wireless
computer.

8 Don’t want to answer

Participant does not want to answer.

`9 No answer recordeda

No answer was recorded.

ANALYSIS AND USE

To determine if the participant has used a desktop/laptop, smartphone, and/or tablet/other
portable wireless computer to understand computer use
To quantify the number of participants who do not use a computer
To facilitate analysis of changes in computer use over time

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
This MDE can be collected during risk reduction counseling sessions, which is offered at all the
assessment visits and at any HBSS sessions. Participant computer use is defined as use of a
personal desktop/laptop, smartphone, or tablet/Other portable wireless computer within the
household.
An error will occur if the type of computer use is not any of the following values: 1,2,7,8,9.

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 21b: IntAcc*

Do you or any member of this household have access to the internet?
This variable indicates if the participant has access to the internet and how the internet is being
provided.

FORMAT

Type:

Numeric

Other Format:

Item Length:

Justification:

Right

Field Length:

Beginning Position:

545

Leading Zeros:

Valid Range:

See values

Static Field:

Yes

N/A

SOURCE

Adapted from American Community Survey

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Yes – by paying a cell
phone company or
internet service provider

Participant reports access to the internet by paying a cell phone
company or internet service provider.

2 Yes – without paying a
cell phone company or
internet service provider

Participant reports access to internet without paying cell phone
company or internet service provider.

3 No access to internet in
this house, apartment, or
mobile home

Participant does not have access to the internet.

7 Don’t know

Participant does not know about their internet access.

8 Don’t want to answer

Participant does not want to answer.

9 No answer recordeda

No answer was recorded.

ANALYSIS AND USE

To determine if the participant has access to the internet for understanding access and
utilization of the internet
To quantify the number of participants without internet access
To facilitate analysis of changes in internet access over time

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
This MDE can be collected during risk reduction counseling sessions, which is offered at all the
assessment visits and at any HBSS sessions. An error will occur if the type of computer use is
not any of the following values: 1,2,3, 7,8,9.

*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

Item 21c: FoodInsec

During the last 12 months, was there a time when you were worried you would run out of
food because of a lack of money or other resources?
This variable indicates if the participant experiences food insecurity in the past year, indicating
potential barriers to program engagement.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

546

Leading Zeros:

Valid Range:

See values

Static Field:

Yes

SOURCE

Adapted from Food Insecurity Experience Scale from Food and Agriculture Organization of the
United Nations

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Yes

Participant reports that they were worried that they might run out
of food because of a lack of money or other resources.

2 No

Participant does not report that they were worried that they might
run out of food because of a lack of money or other resources.

7 Don’t know

Participant does not know about their food insecurity.

8 Don’t want to answer

Participant does not want to answer.

9 No answer

recordeda

No answer was recorded.

ANALYSIS AND USE

To determine the number of participants who experience food insecurity
To facilitate analysis of food insecurity over time
To quantify potential barriers to program engagement

OTHER
INFORMATION

aCodes

and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
This MDE can be collected during risk reduction counseling sessions, which is offered at all the
assessment visits and at any HBSS sessions.

WISEWOMAN MDE Manual
Version 23.1

Item 21d: TranBarr

Have you ever missed a doctor’s appointment because of transportation problems?
This variable indicates if the participant has transportation barriers to accessing clinical and
support services.

FORMAT

Type:

Numeric

Other Format:

Item Length:

Justification:

Right

Field Length:

Beginning Position:

547

Leading Zeros:

Valid Range:

See values

Static Field:

Yes

N/A

SOURCE

Adapted from Locatelli, S. M., Sharp, L. K., Syed, S. T., Bhansari, S., & Gerber, B. S. (2017).
Measuring Health-related Transportation Barriers in Urban Settings. Journal of applied
measurement, 18(2), 178–193.

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Yes

Participant reports that they have missed a doctor’s appointment
because of transportation problems.

2 No

Participant does not report having missed a doctor’s appointment
because of transportation problems.

7 Don’t know

Participant does not know about their past transportation issues.

8 Don’t want to answer

Participant does not want to answer.

9 No answer

recordeda

No answer was recorded.

ANALYSIS AND USE

To determine the number of participants who have ever experienced issues in accessing
healthy behavior support services due to transportation barriers
To facilitate analysis of transportation barriers over time
To determine areas where participants have additional transportation barriers
To understand magnitude of potential barriers to program engagement

OTHER
INFORMATION

aCodes

WISEWOMAN MDE Manual
Edition 23.1

Item 21e: Childcare

If you are you currently using childcare services, please identify the type of services you
use, if not select Not Applicable.
This variable indicates whether the participant uses childcare services. If childcare services are
used, the variable what type(s) of childcare services that participants have used in the past
year.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

548

Leading Zeros:

Valid Range:

Static Field:

Yes

See values, cannot be
blank if valid value
provided for ChildBarr

SOURCE

Adapted from Child Care Needs Assessment Survey from Virginia State University

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Infant (Birth to 11
months)

Participant reports using childcare services for infants.

2 Toddler (11 to 36
months)

Participant reports using childcare services for toddlers.

3 Preschool (3 to 5 years)

Participant reports using childcare services for preschool-aged
children.

4 After School Care (K-9th
grade)

Participant reports using childcare services for after school care
for kindergarten through 9th grade-aged children.

5 Not applicable

Participant does not report using childcare services.

7 Don’t know

Participant does not know the type of childcare services they
have used.

8 Don’t want to answer

Participant does not want to answer.

9 No answer

recordeda

No answer was recorded.

ANALYSIS AND USE

To determine the number of participants who have ever experienced issues in access support
services due to childcare services
To facilitate analysis of transportation barriers over time
To understand magnitude of potential barriers to program engagement

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
This MDE can be collected during risk reduction counseling sessions, which is offered at all the
assessment visits and at any HBSS sessions.
This variable can potentially have multiple responses selected. For example, if participant
utilizes childcare services for an infant and for after school care, option 1 and option 4 should be
selected.

WISEWOMAN MDE Manual
Edition 23.1

Item 21f: ChildBarr

Have you had any of these child-care related problems during the past year? (Select all
that apply)
This variable indicates whether the participant uses childcare services. If childcare services are
used, the variable what type(s) of childcare related problems that participants have faced in the
past year.

FORMAT

Type:

Numeric

Other Format:

Item Length:

Justification:

Right

Field Length:

Beginning Position:

552

Leading Zeros:

Valid Range:

See values

Static Field:

Yes

N/A

SOURCE

Adapted from Child Care Needs Assessment Survey from Virginia State University

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Cost

Participant reports childcare barriers related to cost in the past
year.

2 Availability

Participant report childcare barriers related to availability in the
past year.

3 Location

Participant reports childcare barriers related to location in the
past year.

4 Transportation

Participant reports childcare barriers related to transportation in
the past year.

5 Hours of Operation

Participant reports childcare barriers related to hours of operation
in the past year.

6 Other

Participant reports other childcare barriers in the past year.

7 Not applicable

Participant does not use childcare services.

8 Don’t know

Participant does not know if they have experienced childcare
related barriers.

9 No answer recordeda

No answer was recorded.

ANALYSIS AND USE

To determine the number of participants who have ever experienced specific childcare related
barriers to program engagement
To facilitate analysis of childcare barriers over time

OTHER
INFORMATION

WISEWOMAN MDE Manual
Edition 23.1

Item 21g: Housing

What is your housing situation today?
This variable indicates participant’s current housing status and potential barriers to program
engagement related to housing.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

558

Leading Zeros:

Valid Range:

See values

Static Field:

Yes

SOURCE

Adapted from NACHC’s Protocol for Responding to and Assessing Patient Assets, Risks, and
Experiences survey

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 I have housing

Participant reports having housing.

2 I have housing, but I am
worried about losing my
housing

Participant reports having housing currently but worries about
future housing status.

3 I do not have housing

Participant reports not having housing.

7 Don’t know

Participant does not know their current housing status.

8 Don’t want to answer

Participant does not want to answer.

9 No answer

recordeda

No answer was recorded.

ANALYSIS AND USE

To determine the number of participants who currently experience housing insecurity
To facilitate analysis of housing insecurity over time
To assess if housing status is related to program engagement

OTHER
INFORMATION

WISEWOMAN MDE Manual
Edition 23.1

NEW Item 21g1:
IntPartSafe

Do you feel physically and emotionally safe where you currently live?

FORMAT

Type:
Numeric
Other Format:
Item Length:
1
Justification:
Field Length: 1
Beginning Position:
Leading Zeros: No
Valid Range:
Static Field:
Yes
Adapted from The PRAPARE Tool

SOURCE
DENOMINATOR
POPULATION
VALUES AND
DESCRIPTION

ANALYSIS AND
USE
OTHER
INFORMATION

This variable indicates if a participant feels safe in their current environment.
N/A
Right
Takes place of “Latino”
See values

The denominator includes all WISEWOMAN participants with a Complete/BP+
baseline assessment.
1 Yes
Participant feels physically or emotionally safe where
they currently live.
2 No
Participant does not feel physically or emotionally safe
where they currently live.
3 Unsure
Participant unsure about feeling physical or emotionally
safe where they currently live.
8 I choose not to
Participant does not want to
answer this question answer this question.
9 No answer recordeda No answer was recorded.
To determine the number of participants who feel physically and emotionally
safe where they currently live.
aCodes and response options highlighted in gray should not appear on the data
collection forms completed by the provider. They are provided for funded
program use.
This MDE can be collected during risk reduction counseling sessions, which is
offered at all the assessment visits and at any HBSS sessions.
If no answer is recorded, the value ‘9’ can be recorded. If a participant chooses
to not answer this question, the value ‘8’ can be recorded.

WISEWOMAN MDE Manual
Edition 23.1

100

NEW Item 21g2:
IntPartSafe

In the past year, have you been afraid of your partner or ex-partner?

FORMAT

Type:
Numeric
Other Format:
Item Length:
1
Justification:
Field Length: 1
Beginning Position:
Leading Zeros: No
Valid Range:
Static Field:
Yes
Adapted from The PRAPARE Tool

SOURCE
DENOMINATOR
POPULATION
VALUES AND
DESCRIPTION

This variable indicates if a participant is afraid of a partner or ex-partner?

The denominator includes all WISEWOMAN participants with a Complete/BP+
baseline assessment.
1 Yes
Participant feels afraid of their partner or ex-partner.
2 No

Participant does not feel afraid of their current or expartner.
Participant unsure about feeling afraid of current of expartner.
Participant has not had a partner in the past year.

3 Unsure

ANALYSIS AND
USE

OTHER
INFORMATION

N/A
Right
Takes Place of “Race2”
See values

4 I have not had
a partner in the
past year
8 I choose not to
Participant does not want to
answer this question answer this question.
9 No answer recordeda No answer was recorded.
To determine the number of participants who are afraid of their current and expartner. This may be related to intimate partner violence (IPV) and the amount of
IPV reported.
To facilitate analysis of IPV over time
To assess if IPV is related to program engagement
aCodes and response options highlighted in gray should not appear on the data
collection forms completed by the provider. They are provided for funded
program use.
This MDE can be collected during risk reduction counseling sessions, which is
offered at all the assessment visits and at any HBSS sessions.
If no answer is recorded, the value ‘9’ can be recorded. If a participant chooses
to not answer this question, the value ‘8’ can be recorded.

WISEWOMAN MDE Manual
Edition 23.1

101

Item 21h: IntPartViol

The following will ask about how safe you feel:
•
How often does your partner physically hurt you?
•
How often does your partner insult or talk down to you?
This variable indicates if and how often a participant feels safe in their current environment.

FORMAT

Type:

Numeric

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

Beginning Position:

559

Leading Zeros:

Valid Range:

See values

Static Field:

Yes

SOURCE

Adapted from Intimate Partner Violence and Sexual Violence Victimization Assessment
Instruments for Use in Healthcare Settings, “Hurt, Insult, Threaten, and Scream tool

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Never

Participant reports never experiencing partner physical or
emotional violence.

2 Rarely

Participant reports rarely experiencing partner physical or
emotional violence.

3 Sometimes

Participant reports sometimes experiencing partner physical or
emotional violence.

4 Fairly Often

Participant reports fairly often experiencing partner physical or
emotional violence.

5 Frequently

Participant reports frequently experiencing partner physical or
emotional violence.

8 Don’t want to answer
9 No answer

Participant does not want to answer.

recordeda

No answer was recorded.

ANALYSIS AND USE

To determine the number of participants who currently experience intimate partner violence
(IPV) and the amount of IPV reported
To facilitate analysis of IPV over time
To assess if IPV is related to program engagement

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
This MDE can be collected during risk reduction counseling sessions, which is offered at all the
assessment visits and at any HBSS sessions.
If a participant does not report a partner, the value ‘9’ can be recorded. If a participant does not
want to answer this question, the value ‘8’ can be recorded.

WISEWOMAN MDE Manual
Edition 23.1

102

Item 21i: MedAdher

These four items are related to medication-taking adherence:
•
Do you ever forget to take your (name of health condition) medicine?
•
Are you careless at times about taking your (name of health condition)
medicine?
•
When you feel better, do you sometimes stop taking your (name of health
condition) medicine?
•
Sometimes if you feel worse when you take your (name of health condition)
medicine, do you stop taking it?
This variable indicates how well the participant adheres to their medication.

FORMAT

Type:

Numeric

Other Format:

Item Length:

Justification:

Right

Field Length:

Beginning Position:

560

Leading Zeros:

Valid Range:

See values

Static Field:

Yes

N/A

SOURCE

Adapted from the Medical Adherence Questionnaire

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

1 Yes

Participant reports experiencing medication adherence issues.

2 No

Participant does not report experiencing medication adherence
issues.

8 Don’t want to answer
9 No answer

Participant does not want to answer.

recordeda

No answer was recorded.

ANALYSIS AND USE

To determine number of participants who have medication adherence issues
To facilitate analysis of medication adherence over time

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
This MDE can be collected during risk reduction counseling sessions, which is offered at all the
assessment visits and at any HBSS sessions.
If any of the four responses apply to the participant, the response should be recorded as “1”“Yes”.

WISEWOMAN MDE Manual
Edition 23.1

103

Item 22a: SocSerID*

Social Service ID
This variable indicates unique ID for participant referral to social service.

FORMAT

Type:

Character

Other Format:

N/A

Item Length:

Justification:

Right

Field Length:

110

Beginning Position:

561

Leading Zeros:

Static Field:

Yes

Valid Range: See
values, cannot be
blank

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Social Service ID

ANALYSIS AND USE

To assess the number of participants referred to social services
To facilitate analysis of number of social service referrals over time

Value representing the social service identifier for a participant

OTHER
INFORMATION

Social Service ID consists of two letters representing recipient’s state, tribal organization, or
territory, last two digits from the current calendar year, the four letters “SSID” denoting it is a
social service, and a two-digit numeric code indicating type of social service referral. Two-digit
numeric codes for referrals should be assigned as: 01 for Computer Use, 02 for Internet
Access, 03 for Food Insecurity, 04 for Transportation, 05 for Childcare, 06 for Housing, 07 for
Intimate Partner Violence, 08 for Medication Adherence, 09 for Mental Health, 10 for Language
Translation, 11 for Substance Abuse, 12 for Other.
Social Service ID should be recorded if Social Service Referral date and Date of Social Services
and Support Utilization is recorded.
Multiple social services can be referred, and this field can take up to eleven social service IDs.
If a participant did not need a social service referral, periods like “ ............ ” can be used to
populate the 10 characters in this field.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

104

Item 22b:
SocSerDate*

Social Service Referral Date
This variable indicates the date that a referral to a social service occurred.

FORMAT

Type:

Numeric

Other Format:

MMDDCCYY

Item Length:

Justification:

Right

Field Length:

Beginning Position:

671

Leading Zeros:

Yes

Valid Range:

Valid date

Static Field:

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Social Service Referral
Date

Valid date in MMDDCCYY format
Date must occur within the submission period.
Example: December 01, 2023 = 12012023

888 Participant refuseda

Participant refused social service referral.
This value will be flagged as a quality check.

ANALYSIS AND USE

To determine the date of the referral to a social service
To assist in determining the number of social service referrals per participant
To facilitate analysis of changes in social service referrals over time

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
Multiple social service referrals can be made on the same date. Each social service referral
date should be paired with a social service ID. A maximum of eleven dates can be recorded.
Social Service referral date should have occurred on the current date or earlier.
Social Service referral date should have occurred before or on the same date as the Date of
Social Services and Support Utilization.
If a participant did not need a social service referral, periods like “ .......... ” can be used to
populate the 8 characters in the date field.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

105

Item 22c: SocSerUtil*

Date of Social Services and Support Utilization
This variable indicates the date that a participant has utilized social services and support.

FORMAT

Type:

Numeric

Other Format:

MMDDCCYY

Item Length:

Justification:

Right

Field Length:

Beginning Position:

759

Leading Zeros:

Yes

Valid Range:

Valid date

Static Field:

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants with a Complete/BP+ baseline
assessment.

VALUES AND
DESCRIPTION

Social Service Utilization
Date

Valid date in MMDDCCYY format
Date must occur within the submission period.
Example: December 01, 2023 = 12012023

888 Participant refuseda

Participant refused social service referral.
This value will be flagged as a quality check.

ANALYSIS AND USE

To determine the date of utilization of social service and support after referral
To understand time and relationship between a social service referral and utilization for a
participant
To assist in determining the number of social service utilizations per participant
To facilitate analysis of changes in social service utilization over time

OTHER
INFORMATION

aCodes and response options highlighted in gray should not appear on the data collection forms
completed by the provider. They are provided for funded program use only.
Multiple social service utilizations for different services can occur on the same date. Each social
services and support utilization date should be paired with a social service ID. A maximum of
eleven dates can be recorded.
Date of Social Services and Support Utilization should have occurred on the current date or
earlier to be valid. Date of Social Services and Support Utilization has to occur after or on the
same date as Social Service Referral Date.
For ongoing social services and support utilization, please record the initial date on which the
participant first accessed the social service.
If a participant did not need a social service referral and did not utilize social services, periods
like “ ......... ” can be used to populate the 8 characters in the date field.
*Complete and BP+ records require a valid response for this item. Refer to Table A.2 in Appendix A for more information.

WISEWOMAN MDE Manual
Edition 23.1

106

APPENDIX A:
ASSESSMENT DEFINITIONS AND SUBMISSION GUIDANCE

WISEWOMAN MDE Manual
Version 23.1

This Appendix provides assessment definitions and submission guidance for MDE files,
including those related to format, procedures, and security. Submissions will not be
processed if recipients fail to follow the guidelines provided below.
Data Submission Guidance
Recipients must submit data to CDC through the Data Management System 3.0. For
additional guidance on data submission, refer to the Data Management System Quick
Reference Guide, available on the WISEWOMAN Data Management System website.
Assessment Definitions
Table A.1 provides an overview of WISEWOMAN assessment definitions. For MDE 18.3,
recipients should report each baseline assessment, follow-up assessment, and reassessment as a separate row in their data file for the reporting period. CDC will use unique
participant identifier (EncodeID), month and year of birth (MYB), and state/tribal FIPS code
(STFIPS) to identify each participant within the data, and the Type field and the clinical
assessment date (BPDate) to determine whether each record represents a baseline
assessment, re-assessment, or follow-up assessment for that participant.
Table A.1. Assessment Definitions
Type

Description

Line Layout of Data

Baseline Assessment

Initial participant assessment; establishes starting
point for WISEWOMAN program

First line

Follow-up
Assessment

Post healthy behavior support service (must occur 3
months and no later than 11 months after a
participant’s baseline assessment or last reassessment and within 4 to 6 weeks after completion
of the LSP/HC)

Second line

Re-assessment

Subsequent assessments occurring 11-18 months
after a participant’s baseline assessment or last reassessment

Third line

CDC will determine whether each submitted baseline assessment, re-assessment, and
follow-up assessment record will be counted as complete or blood pressure plus (BP+) using
the criteria described below, and further detailed in Table A.2.
A complete record, at minimum, includes valid values for the following MDEs:1

•

Administrative and Demographic items (1a-3f)

•

Disease Status and Health History (4a-4b)

•

Medication Use, Aspirin Use, and Medication Adherence (5a-5c)

•

Nutrition (7a – 7e) and Physical Activity (8a)

•

Smoking Status (9a)

•

Stress (10a)

Invalid values are defined in Table A.2 below and in the Edits documentation, which is available in the Data Management
System 3.0.

WISEWOMAN MDE Manual
Edition 23.1

A.1

•

Height (11a) / Weight (11b)

•

Clinical Assessment Date (12a)

•

Blood Pressure (12b-12c)

•

Fasting Status (13a)*

•

Cholesterol (14a-14c)*

•

Blood Sugar (15a or 15b)*

•

Risk Reduction Counseling (17a)

•

LSP/HC Referral Date (18a)

•

LSP/HC Received (count) (19a)

•

Computer Use (21a)

•

Internet Access (21b)

•

Social Service ID (22a)

•

Social Service Referral Date (22b)

•

Date of Social Services and Support Utilization (22c)

A BP+ record, at minimum, includes valid values for the following MDEs:
•

Administrative and Demographic items (1a-3f)

•

Disease Status and Health History (4a-4b)

•

Medication Use, Aspirin Use, and Medication Adherence (5a-5c)

•

Smoking Status (9a)

•

Height (11a) / Weight (11b)

•

Clinical Assessment Date (12a)

•

Blood Pressure (12b-12c)

•

Fasting Status (13a)*

•

Cholesterol (14a-14c)*

•

LSP/HC Referral Date (18a)

•

LSP/HC Received (count) (19a)

•

Social Service Referral Date (22b)

*Labs may not be medically required for certain participants at follow-up assessment,
therefore, will not be included in the definition of complete and BP+ at this type of visit.
WISEWOMAN MDE Manual
Edition 23.1

A.2

Data Conventions
This section provides an overview of the data file format and layout for the MDEs. It defines
data length and position and describes the types of MDE data. The data conventions
described here represent the raw file format and layout of MDEs that recipients must follow
when submitting data to the Data Management System 3.0 website.
•

Data Types. There are several data types, including date, geographic, character, and
numeric.
o Dates have the format MMDDCCYY.


MM represents the month and has a range of 01–12; use leading zeros
with months 01–09. If month is missing, month is blank (as indicated by a
period [.] in each blank position).



DD represents the day of the month and has a range of 01–31; use
leading zeros with days 01–09. If day is missing, day is blank (as
indicated by a period [.] in each blank position).



CC represents the century and has a range of 19–20. If century is
missing, century is blank (as indicated by a period [.] in each blank
position).



YY represents the year and has a range of 00–99; use leading zeros with
years 00–09. If year is missing, year is blank (as indicated by a period [.]
in each blank position).

o Geographic data elements are state/tribal FIPS code, ANSI county code, county
of residence, and ZIP code of residence. These are character variables and
require leading zeros to fill the field length.
o Character data elements are composed of letters of the alphabet, numbers, and
special characters. These are left-justified, and in cases where the value does
not fill the entire field length, extra spaces in the length should be left blank (as
indicated by a period [.] in each blank position). If there are no data for a given
MDE, all positions should either be filled with a period [.] or left blank.
o Numeric data elements are composed of numbers, minus signs, and decimal
points. Numeric data elements are right justified. If numbers are expected to the
right of the decimal, the number of decimal places required is indicated in the
MDE specification. In cases where the value does not fill the entire field length,
leading zeros should be used to fill the field length.
•

Item Length. Item length represents the number of characters (i.e., letters of the
alphabet, numbers, and special characters) for one entry of the item.

•

Field Length. If the data element may be collected more than one time during the
assessment, such as Intervention which captures the date of an LSP or HC session,
the field length will allow for multiple entries of this data element.

•

Static Field. If the field is static, it should not be updated or modified after the first time
the element is recorded. For example, month and year of birth is considered a static
field because it is not expected that a participant’s date of birth would change over

WISEWOMAN MDE Manual
Edition 23.1

A.3

time. However, blood pressure measurements are not static fields since it could
change over time.
•

Beginning Position. Position is the location in the record of a data element. The
length and position of each data element are provided in the MDE specifications.

The table below summarized the position, item length, and field length for the MDE variables.
Cells with an ‘X” indicate that an MDE variable is required to be valid for either a baseline
assessment, re-assessment, or follow-up assessment to count as either complete record or
BP+ record.

WISEWOMAN MDE Manual
Edition 23.1

A.4

Table A.2. MDE Item Format and Invalid Values
Position

Item
Number

MDE Name

Item
Length

Field
Length

Complete

BP+

Invalid Values
(for required items)

StFips

Blank or not an allowable value*

HdANSI

Blank**

EnrollSiteID

Blank**

ScreenSiteID

Blank**

TimePer

Blank, out of range, or not an allowable value* if the record is a
baseline assessment

Nscreen

Blank

Type

Blank, coded as missing (9), or not an allowable value*

Navigation

Blank or not an allowable value*

EncodeID

Blank

ResANSI

Blank**

Zip

Blank, coded as missing (99999) or not a valid 5-digit zip code

MYB

Blank

Latino

Blank, coded as missing (9), or not an allowable value*

Blank, coded as missing (9), or not an allowable value*
Exception: Values of missing (9) are permitted if the participant is
Latino

Race1

Race2

Education

Language

SRC

First, second, or third position blank, coded as missing (9), or not an
allowable value*

SRHA

First, second, third, fourth, fifth, sixth, seventh, eighth, or ninth
position blank, coded as missing (9) or not an allowable value*

Meds

First, second, third, or fourth position blank, coded as missing (9) or
not an allowable value*

Aspirin

Blank, coded as missing, or not an allowable value*

Any set of two positions blank, coded as missing (99), out or range
(>07), incorrectly coded as not applicable (55) for participants who
were prescribed medication, or incorrectly coded as 01 through 07
days for participants who were not prescribed medication

MedAdhere

Monitored

WISEWOMAN MDE Manual
Edition 23.1

A.5

Position

Item
Number

111

112
113

MDE Name

Item
Length

Field
Length

Complete

BP+

Invalid Values
(for required items)

BPHome

BPFreq

BPSend

114

FruitVeg

Blank, coded as missing (99), or out of range (>65)

116

Fish

Blank, coded as missing (9), or not an allowable value*

117

Grains

Blank, coded as missing (9), or not an allowable value*

118

Sugar

Blank, coded as missing (9), or not an allowable value*

119

SaltWatch

Blank, coded as missing (9), or not an allowable value*

120

AlcFreq

122

AlcDay

124

Blank, coded as missing (9999)

128

Smoker

129

10a

PHQ

131

11a

Height

Blank or coded as unable to obtain (77), refused (88), missing (99),
or out of range (<48; >76)

133

11b

Weight

Blank, coded as missing (999), or out of range (<74; >460)

136

11c

Waist

138

12a

BPDate

Blank or illogical entry (e.g., date is in the future or is a non-numeric
value)

146

12b

SBP

Position 1, 2, and 3 are blank or coded as unable to obtain (777),
refused (888), missing (999), or out of range (<74; >260)

158

12c

DBP

Position 1, 2, and 3 are blank or coded as unable to obtain (777),
refused (888), missing (999), or out of range (<002; >156)

170

13a

Fast

X****

Blank, coded as missing (9) if Type = 1 or 2

171

14a

TotChol

X****

Blank, coded as unable to obtain (777), refused (888), missing (999),
or out of range (<44; >702) if Type = 1 or 2

174

14b

HDL

X****

Blank, coded as unable to obtain (777), refused (888), missing (999),
or out of range (<7; >196) if Type = 1 or 2

X****

Blank, coded as unable to obtain (777), refused (888), missing (999),
or out of range (<20 or >380) if Type = 1 or 2
Note: Any value will be invalid for nonfasting participants who are on
lipid-lowering therapy, have a history of high cholesterol, or have a
triglyceride level >400 mg/dL

177

14c

LDL

WISEWOMAN MDE Manual
Edition 23.1

X****

A.6

Blank, coded as missing (9), or not an allowable value*
First or second position is blank, coded as missing (9), or not an
allowable value*

Position

Item
Number

MDE Name

Item
Length

Field
Length

Complete

Invalid Values
(for required items)

BP+

180

14d

Trigly

184

15a

Glucose***

X****

187

15b

A1C***

X****

191

16a

BPAlert

192

16b

BPDiDate

200

17a

RRCComplete*****

208

18a

RefDate

Illogical entry (e.g., date is in the future)

224

19a

LSPHCRec

Blank if referral date is valid

226

19b

Intervention

128

354

19c

LSPHCID

160

514

20a

TobResDate

538

20b

TobResType

541

20c

TResComp

544

21a

CompUse

Blank, Value ≠ (1, 2, 7, 8, 9)

545

21b

IntAcc

Blank, Value ≠ (1, 2, 3, 7, 8, 9)

546

21c

FoodInsec

547

21d

TranBarr

548

21e

Childcare

Blank

552

21f

ChildBarr

558

21g

Housing

559

21h

IntPartViol

560

21i

MedAdher

561

22a

SocSerID

110

671

22b

SocSerDate

759

22c

SocSerUtil

847

End

Complete String
Count

WISEWOMAN MDE Manual
Edition 23.1

A.7

Participant is fasting and glucose is blank or coded as unable to
obtain (777), refused (888), missing (999) or out of range (<37 or
>571), and A1C is blank or coded as unable to obtain (7777),
refused (8888), missing (9999) or out of range (<2.8 or >16.2) and
Type = 1 or 2; OR participant is not fasting and A1C is blank or
coded as unable to obtain (7777), refused (8888), missing (9999) or
out of range (<2.8 or >16.2) and Type = 1 or 2

Blank

Refused (888), SocSerDate > [current date], SocSerDate >
SocSerUtil
Refused (888), SocSerUtil > [current date], SocSerUtil < SocSerDate

* Values are considered not allowable if they are not one of the listed response categories for categorical items
** A string of zeros is not a valid response for this item.
*** Only A1c OR Glucose is required for Complete assessments (baseline and re-assessment only), recipients do not need to collect both
****Labs may not be medically required for certain participants at follow-up assessment, therefore, will not be included in the definition of complete and BP+ at this visit
***** Program flow requires Risk Reduction Counseling at every assessment. Date does not need to be entered in MDE file for BP+

WISEWOMAN MDE Manual
Edition 23.1

A.8

Submission Procedures
It is important to account for all WISEWOMAN services provided through funding dollars so
recipients must submit all data for every participant (e.g., Complete, BP+, and incomplete
records).
Please submit only one file containing all assessment records. Recipients should upload their
submission to the DMS 3.0 as a fixed-format ASCII text file. MDEs must be recorded in the
locations identified in the MDE specifications. Each record in the file should represent data for
a unique assessment visit (baseline assessment, follow-up assessment, re-assessment) with
all associated activities. The associated activities may include LSP and/or health coaching
(HC) contacts. Each data element must conform to the format and values as specified. Files
must include data for the appropriate time period.
For recipients choosing to submit Supplemental LSP/HC data for lifestyle program and health
coaching referrals and sessions that exceed the capacity of the MDE file, please read the
instructions which can be found in TA Resources under the Library tab inside DMS 3.0 and in
Appendix B. Files should be named using the format PPYYMM where PP is the program
abbreviation and YYMM is the date of the submission. YY is the two-digit year, and MM is the
month from 01 to 12. Recipients should use leading zeros when specifying years and months
between 01 and 09. An example of a valid file name is PA2404.
Recipients are encouraged to begin validating their data at least four weeks prior to the
submission date. If help is needed, please contact your CDC project officer or the CDC Data
Team.
Data managers for each recipient have been provided with a username and password to log
into the web-based WISEWOMAN Data Management System 3.0. Other recipient staff will be
provided with a separate username and password upon request. Prior to submission,
recipients should prepare bulk data files as instructed for the relevant period and run it
through the online validation tool to identify errors and quality checks. These errors and
quality checks should be addressed to the extent possible prior to submission. See Appendix
B for forms that recipients may submit along with their MDE data file.
As the data contractor prepares the analytic file after programs’ final submissions, data
issues may be identified for immediate correction. In these instances, project officers will
notify programs that there are data issues for correction and will follow up with programs
about making these corrections. The project officer will act as a liaison to the data contractor
on these issues. Programs will resubmit corrected data through the WISEWOMAN website
and notify their project officers.
Data Confidentiality and Security
This section describes the data confidentiality and security guidelines for preparing and
submitting MDE data. Data and documents submitted via the WISEWOMAN website will be
encrypted during transmission. Programs must not send information that will allow
participants to be identified and must use encoded identifiers and so on to uniquely identify
participants’ data. In addition, data submissions must be de-identified pursuant to the Health
Insurance Portability and Accountability Act of 1996 (HIPAA).
WISEWOMAN MDE Manual
Edition 23.1

A.9

MDE data are “limited data sets” in which all identifying information has been removed, with
the exception of encoded participant ID, county of residence, ZIP code of residence, birth
month and year, Hispanic origin, and race. The participant ID must not be linked to any other
external datasets containing personal information. Submissions must not include any of the
identifiers stipulated in HIPAA.
Recipients are expected to implement data security procedures that will secure participant
identifying and health information, including those related to back-up, hardcopy and electronic
storage, and transmission. Additional information about CDC data security procedures can be
requested.

WISEWOMAN MDE Manual
Edition 23.1

A.10

APPENDIX B:
DATA QUALITY AND VALIDATION

CDC is committed to ensuring that the data submitted are accurate, valid, reliable, and
complete, and provides recipients with several tools to help monitor and improve data quality.
This section describes three items: online validation through the Data Management System
3.0; data validation procedures and forms; and the method for calculating error rates. These
items together form a data quality system that allows the identification and
validation/correction of out-of-range values, improbable values, and missing data (unknown,
refused, and not obtained). It also provides an assessment of data quality through an error
rate calculation algorithm.
Validation of Data
Online validation will be available through the WISEWOMAN Data Management System 3.0.
Instructions for validating data are available in the WISEWOMAN Quick Reference Manual
resource in the “Documents” tab of the Data Management System 3.0.
CDC distinguishes between errors and quality checks using the following definitions.
•

Errors are out-of-range and missing values for variables that are critical to
assessment of program performance, management, and areas for improvement.
Responses that are not considered programmatically acceptable may also be defined
as errors.

•

Quality Checks are values that seem improbable but are still possible; should be
available but are unknown, refused, or unable to be obtained; are not required but are
missing; or are contrary to medical guidance.1 Responses that may be clinically
problematic may also be highlighted for quality checks along with values that are
programmatically problematic, i.e., values that do not align with program guidance,
such as ages outside of 35-64 years.

Prior to data submission, programs should ensure that their data are validated. Programs are
encouraged to check on the validity of their data multiple times before the deadline to
maximize data quality. Whenever possible, errors should be corrected, and quality check
values validated before the data are submitted to CDC.
As needed, the online validation provided on the web-based WISEWOMAN website will be
updated by the data contractor to reflect any changes in specifications and to account for
nuances discovered about the data. Any changes will be documented in the MDE manual
and edits documentation.

1 Valid values for items used to determine a complete or BP+ screening record are provided in Table A.2.

WISEWOMAN MDE Manual
Edition 23.1

B.2

Data Validation Procedures and Forms
Specific response options for some data elements require that recipients provide information
in addition to that in the MDE data files. This section describes the procedures and forms that
can be used to validate or explain values in the MDE data submitted, to provide explanation
for alerts not seen within seven days, to notify CDC of changes in participants’ unique IDs, to
make corrections to previous MDE data, and report on additional LSP/HC sessions.
Validation or Explanation of Values
When MDE values are flagged as errors, recipients can confirm these values to be valid or
provide further explanation about them using the Validation of Data form (recipients are not
required to provide further explanation for quality checks). This form can be completed on the
web-based WISEWOMAN Data Management System 3.0 at the time of MDE submission and
by the submission deadline.
Values for validation or explanation fall into the following general categories:
•

Out-of-range values. These will be identified as quality checks or errors. In general,
values that are highly unusual will be identified as quality checks, while values that are
nearly impossible or are not a response option for a categorical field will be identified
as errors. For example, heights less than 48 inches will be flagged as errors. Because
such a height would result in an error for this record, the program might confirm this
height by submitting an entry in the Validation of Data form and explaining the
circumstances of the error.

•

Responses coded as participant refused. Although participants can refuse any
question or clinical service, it may be appropriate to inform CDC why the program has
chosen to include a participant who refuses basic assessment or assessment services
as a participant in the program.

•

Other. Other errors flagged for which the recipient would like to provide an
explanation.

Notification of Participant Unique ID Changes
If the participant unique ID number changes for one or more participants between
submissions, recipients must notify CDC of the change by submitting a Participant ID Change
Form, which details the participant unique IDs affected. This form can be completed on the
web-based WISEWOMAN Data Management System 3.0. Identifying these changes is
critical to accurately link records between periods and follow participant changes over time.

WISEWOMAN MDE Manual
Edition 23.1

B.3

Error Rate Calculation Method
This section provides the method used to calculate error rates. The WISEWOMAN website
will generate a validation report for immediate viewing through the online validation tool. The
report contains an error rate calculated for the entire submission. There are 71 variables, with
131 possible errors in Complete records and 105 possible errors in BP+ records. The error
rate is calculated using the following formula:
1. Complete error score calculation:
= # of Errors / (# of Possible Errors in Complete Records)
2. BP+ error score calculation:
= # of Errors (excluding errors on the 14 MDEs not required for BP+) / (# of Possible
Errors in BP+ Records)
Notes:
− The number of possible errors in Complete records are 131.
− The number of possible errors in BP+ records are 105.
− The 14 MDEs required for Complete and not BP+ include: FruitVeg, Fish, Grains,
Sugar, SaltWatch, PA, PHQ, Glucose, A1C, RRCComplete, CompUse, IntAcc,
SocSerID, SocSerUtil
− Errors on the 14 MDEs listed above should be excluded from the numerator.
3. Weighted error score calculation:
(Complete Error Rate * (# Complete Records / # Complete & BP+ records)) +
(BP+ Error Rate * (# BP+ records / # Complete & BP+ records))
Programs can provide explanations for any errors by submitting to CDC the Validation of
Data form shown at the end of this Appendix. The calculation of the final error rate will be
conducted following the final submission and review of documentation provided by programs.

WISEWOMAN MDE Manual
Edition 23.1

B.4

Validation of Data Form
The Validation of Data Form should be filled out to validate or explain any values submitted.
These values will include mainly those flagged as errors. (See the Documents tab in Data
Management System 3.0 for a list of errors and quality checks). CDC will review the
information provided in this form and consider these values in the calculation of the error rate.
Your program staff should use the web-based WISEWOMAN Data Management 3.0 System
to review and verify each value in the form. To fill out this form, go to the Miscellaneous
Forms tab of the Data Management System 3.0 and select "Go to Validation of Data Form."
Select "Create New Validation of Data record" for each MDE item to be validated. The
following information is needed for each record:
•

StFIPS. Provide your state or tribal code for the record to be validated/explained.

•

Validation Type. Identify whether the validation or explanation is for an error (E),
quality check (Q), or some other issue (O).

•

BPDate. Provide the BPate for the record to be validated/explained.

•

EncodeID. Provide the participant unique ID number for the record to be
validated/explained.

•

MDE Item Number. Provide the MDE item number associated with the error, quality
check, or other value for validation/explanation.

•

MDE Value. Provide the value or code (e.g., numeric value for height, ‘7 unknown’) to
be verified/explained.

•

Explanation. Provide an explanation for the value (e.g., review of hard-copy record,
discussion with provider verified value).

WISEWOMAN MDE Manual
Edition 23.1

B.5

Participant ID Change Form
The Participant ID Change Form should be filled out when a participant’s Encode ID has
changed since a previous submission. The correct Encode ID for a participant is needed to
track participant data over time. Your program staff should use the web-based WISEWOMAN
Data Management 3.0 System to review and verify each value in the form. To complete this
form, go to the Miscellaneous Forms tab on the Data Management System 3.0 and select
"Go to Participant ID change records." Select "Create New Participant Change Record" for
each ID that changed. The following information is needed for each changed ID:
•

StFIPS. Provide your state or tribal code as entered for the participant with the new
Encode ID.

•

OrigEncodeID. Provide the original participant unique ID number for the participant.

•

NewEncodeID. Provide the new, changed participant unique ID number for the
participant.

•

ChangeDate. Provide the date that the EncodeIDs were changed.

•

ReassignedDate. If the original EncodeID has been reassigned to a new participant,
provide the date of the reassignment here; otherwise, leave this field blank.

WISEWOMAN MDE Manual
Edition 23.1

B.6

Correction to Previous MDE File Form
The Correction to Previous MDE File Form may be filled out when modifications have been
made to an assessment record that had been previously submitted to CDC. Recipients are
not required to submit this form but may choose to submit it if they would like to provide an
explanation to CDC about significant updates or corrections made to previously submitted
data.
Your program staff should use the web-based WISEWOMAN Data Management 3.0 System
to review and verify each value in the form. To complete this form, go to the Miscellaneous
Forms tab on the Data Management System 3.0 and select "Go to MDE Correction Form."
Select "Create New MDE Correction Record" for each record change to be documented. The
following information is needed for each corrected record:
•

StFIPS. Provide your state or tribal code as entered for the participant with the new
Encode ID.

•

EncodeID. Provide the original participant unique ID number for the participant.

•

Office Visit. Provide the office visit date (BPDate) for the assessment that the
corrections affect.

•

Screening Number. Provide the number of assessments received by the participant
(NScreen) as of the assessment that the corrections affect.

•

Type of Revision. Select one of the following options from the dropdown menu:
Added New Records for previous periods, Edited Existing Record, Dropped Records
for previous period.

WISEWOMAN MDE Manual
Edition 23.1

B.7

Supplemental Lifestyle Program and Health Coaching (LSP/HC) Session Spreadsheet
The current MDE file format allows for documentation of up to two LSP/HC referrals and up to
16 LSP/HC sessions for each assessment. If a participant receives more than two LSP/HC
referrals and/or attends more than 16 LSP/HC sessions, recipients may choose to record and
submit these data to CDC for the purposes of program monitoring and/or evaluation.
Each value in the form should be reviewed and verified by program staff. The form and
detailed instructions for completing the form are available under the DMS Documents Library
of the WISEWOMAN Data Management System 3.0. The instructions include examples for
completing the form when a participant attends more than 16 LSP/HC sessions associated
with an assessment and when a participant receives more than two LSP/HC program
referrals associated with an assessment. The supplemental form should be uploaded under
the Miscellaneous Forms tab by selecting “Go to Upload Supplemental Forms” and then
“Upload New Supplemental Form.” The following fields are included the in the form:
•

Screening Number. Provide the number of assessments received by the participant
(NScreen) as of the assessment associated with the HC/LSP.

•

EncodeID. Provide the original participant unique ID number for the participant.

•

BPDate. Provide the office visit date (BPDate) for the assessment (baseline
assessment or re-assessment) that the corrections affect.

•

RefDate. Provide the date of the HC or LSP referral.

•

Intervention. Provide the HC or LSP session dates.

WISEWOMAN MDE Manual
Edition 23.1

B.8

APPENDIX C:
DATA ANALYSIS AND USE

MDEs provide a rich source of data for the WISEWOMAN Program. CDC and recipients use
MDEs in a variety of ways to monitor and assess progress and performance. This Appendix
describes the data summary report generated with every submission and other data uses for
the MDEs by CDC. It also discusses potential ways in which recipients can use the data.
Data Summary Report Format and Content
MDE data submissions are used to generate biannual program-specific and aggregate MDE
reports. CDC and recipients use these reports to gauge program progress in meeting goals
and identify areas for improvement. For example, CDC project officers may use these reports
to help identify areas for technical assistance, and recipients may use them to detect areas
where further provider training is needed. Uses of MDE data are discussed in greater detail in
the subsections below.
Additional information about the data summary report format and content will be provided
once available.
Data Use by CDC
WISEWOMAN MDEs support three major objectives: 1) public health practice through
continuous program improvement, 2) program performance, and 3) assessing program health
outcomes through evaluation.
Potential Data Use by Funded Programs
Recipients use MDEs in a variety of ways to drive program improvement and track program
progress. Below are some examples of MDE use among funded programs.
•

Analysis of provider performance. Recipients have used MDEs to track the number
of assessments and LSP/HC sessions conducted by provider sites. In addition, some
have created program-level performance measures that they calculate for individual
providers.

•

Identification of areas for provider trainings. Recipients have used MDEs to
identify areas where provider sites needed training or technical assistance.

•

Assessment of performance in comparison to national benchmarks. Recipients
have used MDEs to assess the characteristics and risks of the population served in
comparison to that for their entire state or the nation.

•

Assessment of participant changes in risk factors. Recipients have used MDEs to
analyze changes between participants’ baseline assessment, re-assessment, and
follow-up assessment visits.

Recipients interested in receiving technical assistance related to using MDEs as a data
source for program monitoring and evaluation should contact their project officer.

WISEWOMAN MDE Manual
Edition 23.1

C.2

APPENDIX D:
TECHNICAL ASSISTANCE RESOURCE

To support recipients in collecting and submitting data, CDC has developed several
strategies and tools to provide technical assistance to recipients. This appendix describes the
various types of technical assistance available to recipients, the web-based WISEWOMAN
Data Management System 3.0, the method for requesting individualized technical assistance,
and the technical assistance Helpdesk.
Types of Technical Assistance Available
Technical assistance available to recipients can be broadly categorized as individualized
technical assistance, group technical assistance, and tools. Below, specific types of technical
assistance/tools within these categories are described. The table at the end of this subsection
summarizes the types of technical assistance/tools by category, provider, and timeline.
Individualized Technical Assistance
•

Data Review Calls. After each MDE submission, summary reports are generated and
may be reviewed with recipients during a data review call. As needed, data quality
reports and other materials may also be reviewed.

•

Helpdesk Requests. Recipients can request individualized technical assistance
through contacting the CDC Data Team. A health scientist from the CDC data team
will collaborate with the data contractor to respond to technical assistance requests.
This type of assistance is tailored to the recipient and the question. More information is
provided in the following subsections of this appendix, “Requesting Individualized
Technical Assistance” and “Helpdesk for Technical Assistance Requests.”

Group Technical Assistance
•

Ad Hoc Data Calls and Trainings. Throughout the course of the year, data issues
affecting a majority of, or all recipients may be identified, either through individualized
technical assistance or because of changes to the MDE submission process and
specifications (e.g., modification of MDE specifications, added MDE variables). As a
result, trainings or group communications may be needed. If the need for these
trainings or group communications cannot be fulfilled at the annual meeting, ad hoc
data calls and trainings will be held.

Tools
•

WISEWOMAN MDE Manual. This manual is a technical assistance tool for recipients.
It provides detailed guidance on the MDE submission process and MDE specifications,
and it will be updated as necessary to stay current with the data submission and
collection requirements. Recipients can access the current edition in the
WISEWOMAN Data Management System 3.0 (wwwn.cdc.gov/wisewoman).

•

Edits Documentation (SQL Spreadsheet). The edits documentation details all the
edits programmed in the validation tool. The documentation provides the coding used
for validation in plain language. It also documents the changes to the edits from the
previous MDE edition. Recipients can access the current edition in the WISEWOMAN
Data Management System 3.0 (wwwn.cdc.gov/wisewoman).

As needed, other tools may be disseminated to recipients.

WISEWOMAN MDE Manual
Edition 23.1

D.2

Summary of Types of Technical Assistance and Tools Available
TA Type

Provider

Timeline

Individual
Data review calls

Project officers and/or data
contractor

Semiannually, after MDE
submission and release of
data summary reports

Helpdesk requests

Data contractor

As needed

Data contractor

As needed

WISEWOMAN MDE Manual

Data contractor

Ongoing

Validation Edits
documentation

Data contractor

Ongoing

Group
Ad hoc data calls and
trainings
Tools

Helpdesk for Individualized Technical Assistance Requests
Technical assistance may be requested by contacting the CDC Data Team.1 Once a request
for technical assistance related to MDEs is received, Helpdesk will automatically confirm
receipt of the request and collaborate with the Health Scientist to resolve the request. For
more complex requests or those requiring project officer input, responses may take more
than 24 hours.
All requests are tracked by Helpdesk staff and the health scientist; this is to ensure that
follow-up is completed for all requests and that responses are satisfactory to the requester. In
addition, project officers will be kept abreast of the technical assistance needs of their
programs. The tracking of technical assistance requests by the Helpdesk, health scientist and
project officers allows CDC to identify common issues to inform Program-wide technical
assistance.

1 Recipients may also choose to telephone individual members of the data contractor team. However, requesting technical
assistance through email or website guarantees that all data contractor team members receive notification of the request,
and therefore requests are more likely to receive a prompt response.

WISEWOMAN MDE Manual
Edition 23.1

D.3

APPENDIX E:
NUTRITIONAL PROMPTS

WISEWOMAN MDE Manual
Edition 23.1

E.2

Source: American Heart Association’s
Life’s Simple 7

WISEWOMAN MDE Manual
Edition 23.1

E.3

Source: American Heart Association’s
Life’s Simple 7

WISEWOMAN MDE Manual
Edition 23.1

E.4

Source: American Heart Association’s
Life’s Simple 7

WISEWOMAN MDE Manual
Edition 23.1

E.5

Source: American Heart Association’s
Life’s Simple 7

File Type	application/pdf
File Title	WISEWOMAN Program MDE Manual 21.3
Subject	This WISEWOMAN MDE Manual was written to provide guidance on the collection and submission of minimum data elements (MDEs) for t
Author	Centers for Disease Control & Prevention;WISEWOMAN
File Modified	2025-03-12
File Created	2025-03-12